PMCID	SENTENCE_NUMBER	SENTENCE	SENTENCE_INDICES	ONTOLOGY_CONCEPT_IDS_LIST
17002498	0	['Adenomatous Polyposis Coli (APC) Is Required for Normal Development of Skin and Thymus\n\nAbstract\n\nThe tumor suppressor gene Apc (adenomatous polyposis coli) is a member of the Wnt signaling pathway that is involved in development and tumorigenesis.']	(0, 248)	['GO:0048538', 'GO:0043588', 'GO:0048538', 'GO:0043588', 'GO:0043588', 'GO:0048538', 'GO:0016055', 'GO:0016055', 'GO:0016055', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:0000704', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0002370']
17002498	1	['Heterozygous knockout mice for Apc have a tumor predisposition phenotype and homozygosity leads to embryonic lethality.']	(249, 368)	['GO_EXT:fatality_or_lethality', 'NCBITaxon:10088', 'PR_EXT:000004122', 'UBERON:0000922']
17002498	2	['To understand the role of Apc in development we generated a floxed allele.']	(369, 443)	['PR_EXT:000004122', 'SO:0000359', 'SO_EXT:0001023']
17002498	3	['These mice were mated with a strain carrying Cre recombinase under the control of the human Keratin 14 (K14) promoter, which is active in basal cells of epidermis and other stratified epithelia.']	(444, 638)	['CL:0002187', 'CL:0000079', 'CL:0002187', 'CL:0000079', 'CL:0002187', 'CL:0002187', 'CL:0000079', 'CL:0000079', 'GO:0007618', 'GO:0065007', 'CL_GO_EXT:cell', 'GO_EXT:recombinase', 'NCBITaxon:10088', 'NCBITaxon:9606', 'PR_EXT:000009454', 'PR_EXT:000009454', 'PR_EXT:000009454', 'SO_EXT:0000167', 'UBERON:0007376', 'UBERON:0000486', 'UBERON:0000486']
17002498	4	['Mice homozygous for the floxed allele that also carry the K14-cre transgene were viable but had stunted growth and died before weaning.']	(639, 774)	['GO_EXT:biological_growth_entity_or_process', 'GO:0016265', 'NCBITaxon:10088', 'PR_EXT:000009454', 'SO:0000359', 'SO_EXT:0001023', 'SO_EXT:0000902']
17002498	5	['Histological and immunochemical examinations revealed that K14-cre–mediated Apc loss resulted in aberrant growth in many ectodermally derived squamous epithelia, including hair follicles, teeth, and oral and corneal epithelia.']	(775, 1001)	['GO_EXT:biological_growth_entity_or_process', 'PR_EXT:000009454', 'PR_EXT:000004122', 'UBERON:0000924', 'UBERON:0006914', 'UBERON:0006914', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0001091', 'UBERON:0002424', 'UBERON:0001772', 'UBERON:0002424', 'UBERON:0001772']
17002498	6	['In addition, squamous metaplasia was observed in various epithelial-derived tissues, including the thymus.']	(1002, 1108)	['UBERON:0000483', 'UBERON:0000479', 'UBERON:0002370']
17002498	7	['The aberrant growth of hair follicles and other appendages as well as the thymic abnormalities in K14-cre; ApcCKO/CKO mice suggest the Apc gene is crucial in embryonic cells to specify epithelial cell fates in organs that require epithelial–mesenchymal interactions for their development.']	(1109, 1397)	['CL:0002321', 'CL:0002321', 'CL:0000066', 'CL:0000066', 'GO_EXT:biological_growth_entity_or_process', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:0000704', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0004529', 'UBERON:0002370', 'UBERON:0000922', 'UBERON:0000483', 'UBERON:0000062', 'UBERON:0000483', 'UBERON:0003104']
17002498	8	["Synopsis\n\nPatients with familial adenomatous polyposis (FAP) and its variant, Gardner's syndrome, will develop hundreds of colorectal polyps."]	(1399, 1540)	['UBERON:0012652']
17002498	9	['It is a heritable disease that is linked to a genetic mutation in the tumor suppressor gene APC (adenomatous polyposis coli).']	(1541, 1666)	['PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:0000704', 'SO_EXT:sequence_alteration_entity_or_process', 'SO_EXT:0000704']
17002498	10	['These individuals also develop extracolonic symptoms, among which are congenital hypertrophy of the retinal pigment epithelium, desmoid tumors, epidermoid cysts, disorders of the maxillary and skeletal bones, and dental abnormalities, suggesting the importance of APC functions in these organs.']	(1667, 1961)	['CHEBI_EXT:26130', 'NCBITaxon:1', 'PR_EXT:000004122', 'UBERON:0001155', 'UBERON:0001782', 'UBERON:0001782', 'UBERON:0001782', 'UBERON:0007376', 'UBERON:0002397', 'UBERON:0004288', 'UBERON:0001474', 'UBERON:0001091', 'UBERON:0000062']
17002498	11	['To understand the role of Apc in development and in organs other than intestine, we generated Apc mutant mice that can conditionally delete the gene when exposed to Cre recombinase.']	(1962, 2143)	['GO_EXT:recombinase', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:sequence_deletion_process', 'SO_EXT:0000704', 'UBERON:0000062', 'UBERON:0000160']
17002498	12	['These mice were mated with K14 (Keratin 14)–cre mice that express Cre recombinase in skin and its appendages.']	(2144, 2253)	['GO:0007618', 'GO:0010467', 'GO_EXT:recombinase', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000009454', 'PR_EXT:000009454', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0004529']
17002498	13	['The authors found that the mutant mice that have lost Apc in K14-cre transgene–expressing tissues were viable, but had stunted growth and died before weaning.']	(2254, 2412)	['GO:0010467', 'GO_EXT:biological_growth_entity_or_process', 'GO:0016265', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000009454', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:0000902', 'UBERON:0000479']
17002498	14	['These mutant mice showed developmental abnormalities not only in skin but also in many epithelial-derived tissues, including teeth and thymus.']	(2413, 2555)	['NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0000483', 'UBERON:0000479', 'UBERON:0001091', 'UBERON:0002370']
17002498	15	['This work demonstrates the importance of Apc in development of many organs, and provides new insights into diagnosis and management of patients with APC mutations.']	(2556, 2719)	['GO:0048513', 'GO:0048513', 'GO:0048513', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:sequence_alteration_entity_or_process', 'UBERON:0000062']
17002498	16	['Introduction\n\nAdenomatous polyposis coli (APC) is a member of the Wnt signaling pathway and one of its known functions is to regulate the levels of β-catenin.']	(2721, 2879)	['GO:0016055', 'GO:0016055', 'GO:0016055', 'GO:0065007', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198']
17002498	17	['Alterations in β-catenin regulation are very common in human tumors [1].']	(2880, 2952)	['GO:0065007', 'NCBITaxon:9606', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198']
17002498	18	['Loss of APC is associated with stabilization of the cytosolic β-catenin that ultimately results in its migration to the nucleus and activating a cascade of events leading to tumorigenesis.']	(2953, 3141)	['GO:0051170', 'GO:0051170', 'GO:0051170', 'GO:0005829', 'GO:0005634', 'PR_EXT:000004122', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198']
17002498	19	['APC also interacts with a multitude of other cellular proteins, including axin-2 (AXIN2), plakoglobin (JUP), Asef (ARHGEF4), kinesin superfamily–associated protein 3 (KIFAP3), EB1 (MAPRE1), microtubules, and the human homolog of Drosophila discs large (DLG1).']	(3142, 3401)	['CHEBI_PR_EXT:protein', 'CHEBI_PR_EXT:protein', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO:0005874', 'NCBITaxon:9606', 'NCBITaxon:7215', 'PR_EXT:000004122', 'CHEBI_PR_EXT:protein', 'PR_EXT:000004527', 'PR_EXT:000004527', 'PR_EXT:000004527', 'PR_EXT:000004527', 'PR_EXT:000009235', 'PR_EXT:000009235', 'PR_EXT:000004257', 'PR_EXT:000004257', 'PR_EXT:000009322', 'PR_EXT:000009322', 'PR_EXT:000009322', 'PR_EXT:000009322', 'PR_EXT:000009322', 'PR_EXT:000009322', 'PR_EXT:000009322', 'PR_EXT:000010170', 'PR_EXT:000010170', 'PR_EXT:000006511', 'PR_EXT:000006511', 'PR_EXT:000006511', 'PR_EXT:000006511', 'PR_EXT:000006511', 'PR_EXT:000006511', 'SO_EXT:0000853']
17002498	20	['These interactions suggest that APC can potentially regulate many cellular functions, including intercellular adhesion, cytoskeletal organization, regulation of plakoglobin levels, regulation of the cell cycle and apoptosis, orientation of asymmetric stem cell division, and control of cell polarization [2,3].']	(3402, 3712)	['CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL:0000034', 'CL:0000034', 'CL_GO_EXT:cell', 'GO:0065007', 'GO_PATO_EXT:biological_adhesion_entity_or_process', 'GO:0065007', 'GO:0051726', 'GO:0042981', 'GO:0051726', 'GO:0042981', 'GO:0051726', 'GO:0051726', 'GO:0042981', 'GO:0098722', 'GO:0098722', 'GO:0098722', 'GO:0098722', 'GO:2000114', 'GO:2000114', 'GO:2000114', 'GO:2000114', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO:0005856', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000004122', 'PR_EXT:000009235']
17002498	21	['APC is a tumor suppressor gene.']	(3714, 3745)	['PR_EXT:000004122', 'SO_EXT:0000704']
17002498	22	['Somatic mutations in APC are frequently found in many sporadic tumors of the colon and rectum.']	(3746, 3840)	['PR_EXT:000004122', 'SO_EXT:sequence_alteration_entity_or_process', 'UBERON:0001155', 'UBERON:0001052']
17002498	23	['Autosomal dominant germline mutations in APC cause familial adenomatous polypois (FAP) and its variant, Gardner syndrome.']	(3841, 3962)	['GO:0030849', 'PR_EXT:000004122', 'SO_EXT:sequence_alteration_entity_or_process']
17002498	24	['FAP patients are characterized by hundreds of adenomatous colorectal polyps, with an almost inevitable progression to colorectal cancer in the third and fourth decades of life [4,5].']	(3963, 4145)	['UBERON:0012652', 'UBERON:0012652', 'UBERON:0000104']
17002498	25	['In addition to colorectal neoplams, these individuals can develop extracolonic symptoms, among which are upper gastrointestinal tract polyps, congenital hypertrophy of the retinal pigment epithelium, desmoid tumors, disorders of the maxillary and skeletal bones, and dental abnormalities [6], suggesting the importance of APC gene functions in these organ systems.']	(4146, 4510)	['CHEBI_EXT:26130', 'NCBITaxon:1', 'PR_EXT:000004122', 'SO_EXT:0000704', 'UBERON:0012652', 'UBERON:0001155', 'UBERON:0001555', 'UBERON:0001555', 'UBERON:0001782', 'UBERON:0001782', 'UBERON:0001782', 'UBERON:0002397', 'UBERON:0004288', 'UBERON:0001474', 'UBERON:0001091', 'UBERON:0000467', 'UBERON:0000467']
17002498	26	['Although the role of APC in the initiation of human colorectal cancer is well established, its role in other tissue and developmental processes are not well understood.']	(4512, 4680)	['NCBITaxon:9606', 'PR_EXT:000004122', 'UBERON:0012652', 'UBERON:0000479']
17002498	27	['Given the importance of regulation of Wnt signaling in embryonic pattern formation and morphogenesis of many organs, mechanistic understanding of APC in development and in extracolonic tissues becomes critical to better assess potential adverse events in humans.']	(4681, 4943)	['GO:0030111', 'GO:0030111', 'GO:0030111', 'GO:0030111', 'GO:0009880', 'GO:0009880', 'GO:0009880', 'GO:0009887', 'GO:0009887', 'GO:0009887', 'NCBITaxon:9606', 'PR_EXT:000004122', 'UBERON:0000922', 'UBERON:0000062', 'UBERON:0001155', 'UBERON:0000479']
17002498	28	['One approach to understand the role of Apc in development is to develop mice with an inactivating Apc mutation.']	(4944, 5055)	['NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:sequence_alteration_entity_or_process']
17002498	29	['Several genetically modified mouse strains for Apc have been described [7–10].']	(5056, 5134)	['NCBITaxon:10088', 'PR_EXT:000004122', 'SO_EXT:0000704', 'SO_EXT:sequence_alteration_process']
17002498	30	['Most of these models, in the heterozygous state, show a gastrointestinal and other tumor predisposition phenotype [7–10].']	(5135, 5256)	['UBERON:0005409']
17002498	31	['Mouse embryos that are homozygous for the genetic modification die during embryogenesis, and some of the models do not survive beyond gastrulation [8,11].']	(5257, 5411)	['GO:0016265', 'GO:0009790', 'GO:0007369', 'NCBITaxon:10088', 'SO_EXT:0000704', 'SO_EXT:sequence_alteration_entity_or_process', 'UBERON:0000922']
17002498	32	['An alternate approach to understand the role of Apc in development and/or in specific tissues is to generate a mouse strain that carries a conditionally modified allele and mate it with a mouse strain that facilitates the modification of the conditional allele in specific cell lineages.']	(5412, 5699)	['CL_GO_EXT:cell', 'GO:0007618', 'CL_GO_EXT:cell', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122', 'SO_EXT:sequence_alteration_process', 'SO_EXT:0001023', 'SO_EXT:sequence_alteration_entity_or_process', 'SO_EXT:0001023', 'UBERON:0000479']
17002498	33	['To assess the role of Apc in different stages of life systematically, we generated mice containing a conditional knockout (CKO) mutant allele of Apc (ApcCKO).']	(5701, 5859)	['NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:0001023', 'UBERON:0000105', 'UBERON:0000105', 'UBERON:0000105']
17002498	34	['These mice were mated with a strain carrying Cre recombinase under the control of the human Keratin 14 (K14) promoter, which is active in basal cells of epidermis and other stratified epithelia.']	(5860, 6054)	['CL:0002187', 'CL:0000079', 'CL:0002187', 'CL:0000079', 'CL:0002187', 'CL:0002187', 'CL:0000079', 'CL:0000079', 'GO:0007618', 'GO:0065007', 'CL_GO_EXT:cell', 'GO_EXT:recombinase', 'NCBITaxon:10088', 'NCBITaxon:9606', 'PR_EXT:000009454', 'PR_EXT:000009454', 'PR_EXT:000009454', 'SO_EXT:0000167', 'UBERON:0007376', 'UBERON:0000486', 'UBERON:0000486']
17002498	35	['We report here that K14 promoter-driven loss of Apc resulted in aberrant development of several organs that require inductive epithelial–mesenchymal interactions, including hair follicle, teeth, and thymus, and resulted in neonatal death in mice.']	(6055, 6301)	['GO:0048513', 'GO:0048513', 'GO:0048513', 'GO:0016265', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000004122', 'SO_EXT:0000167', 'UBERON:0000062', 'UBERON:0000483', 'UBERON:0003104', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0001091', 'UBERON:0002370', 'PATO_UBERON_EXT:neonate_or_newborn']
17002498	36	['We found that Apc plays a crucial role in determinations of cell fates during the embryonic development, possibly via temporal and tissue-specific regulation of β-catenin levels in the skin, its appendages, and in the thymus.']	(6302, 6527)	['CL_GO_EXT:cell', 'GO:0001709', 'GO:0001709', 'GO:0001709', 'GO:0001709', 'GO:0009790', 'GO:0009790', 'GO:0065007', 'CL_GO_EXT:cell', 'PR_EXT:000004122', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'UBERON:0000922', 'UBERON:0000479', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0004529', 'UBERON:0002370']
17002498	37	['Results\n\nGeneration of the ApcCKO and ApcΔ580 Mice\n\nTo investigate the role of Apc in development of skin and its appendages, we used the Cre/loxP technology to introduce a conditional mutation of the Apc gene in mice.']	(6529, 6747)	['GO:0043588', 'GO:0043588', 'GO:0043588', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:0000346', 'SO_EXT:sequence_alteration_entity_or_process', 'SO_EXT:0000704', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0004529']
17002498	38	['We constructed embryonic stem (ES) cells and mice carrying an Apc allele harboring both a pair of loxP sites flanking Apc exon 14 and a pair of FLP recognition target (FRT) sites flanking PGK-neomycin selection cassette by recombineering [12,13] (Figure 1A, ApcCKON allele, N for neomycin cassette).']	(6748, 7047)	['CHEBI:7507', 'CHEBI_GO_EXT:neomycin_or_neomycin_phosphotransferase', 'CHEBI:7507', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL:0002322', 'CL_GO_EXT:cell', 'GO_EXT:phosphoglycerate_kinase', 'CHEBI_GO_EXT:neomycin_or_neomycin_phosphotransferase', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:P03870', 'PR_EXT:000004122', 'SO_EXT:0001023', 'SO_EXT:0000346', 'SO_EXT:0000346', 'SO:0000357', 'SO_EXT:0000147', 'SO_EXT:0000350', 'SO_EXT:0000350', 'SO_EXT:0000350', 'SO_EXT:0000350', 'SO_EXT:0000350', 'SO_EXT:0000350', 'SO:0000357', 'SO_EXT:0005853', 'SO_EXT:0001023', 'SO_EXT:0005853', 'UBERON:0000922']
17002498	39	['A PGK-neomycin cassette was inserted in the same transcriptional orientation as Apc in intron 14 of the endogenous gene.']	(7048, 7168)	['CHEBI:7507', 'GO_EXT:transcription', 'GO_EXT:phosphoglycerate_kinase', 'PR_EXT:000004122', 'SO_EXT:0005853', 'SO_EXT:sequence_insertion_process', 'SO_EXT:0000188', 'SO_EXT:0000704']
17002498	40	['The loxP and FRT sites were used to aid unidirectional recombination [12,13].']	(7169, 7246)	['GO_SO_EXT:sequence_rearrangement_process', 'SO_EXT:0000346', 'SO_EXT:0000350', 'SO_EXT:0000346', 'SO_EXT:0000350', 'GO_SO_EXT:sequence_rearrangement_process']
17002498	41	['Two mouse lines containing the same modification were generated from two independent ES clones to ensure that these two lines behave in the same way.']	(7247, 7396)	['CL:0002322', 'GO_PATO_EXT:biological_behavior', 'NCBITaxon:10088', 'SO_EXT:sequence_alteration_entity_or_process', 'SO_EXT:sequence_cloned_entity']
17002498	42	['These ApcCKON/+ mice were crossed with FLPe-deleter to generate ApcCKO/+ mice that were heterozygous for the final Apc conditional (ApcCKO) allele that removed the PGK-neomycin cassette and contains only the loxP sites in the introns flanking exon 14.']	(7397, 7648)	['CHEBI:7507', 'GO_EXT:phosphoglycerate_kinase', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:0001023', 'SO_EXT:0005853', 'SO_EXT:0000346', 'SO_EXT:0000346', 'SO_EXT:0000188', 'SO:0000357', 'SO_EXT:0000147']
17002498	43	['To assess the effect of deleting exon 14 in mice, both lines of ApcCKO/+ mice were crossed with the Cre-deleter to generate the germline knockout line of Apc, designated ApcΔ580/+.']	(7649, 7829)	['NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:sequence_deletion_process', 'SO_EXT:0000147', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:normal_or_wild_type_or_present']
17002498	44	['The mutant allele (ApcΔ580) lacks exon 14 (Figure 1A).']	(7830, 7884)	['PR_EXT:000004122', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:0001023', 'SO_EXT:0000147']
17002498	45	['The transcript from loss of exon 14 results in a shift in the normal reading frame, resulting in a premature chain termination codon which, if utilized, would result in a truncated polypeptide that is 605 aa in length, of which the first 580 aa correspond to the normal Apc protein.']	(7885, 8167)	['CHEBI_SO_EXT:polypeptide', 'CHEBI_SO_EXT:amino_acid', 'CHEBI_SO_EXT:amino_acid', 'CHEBI_PR_EXT:protein', 'GO_SO_EXT:frameshift_entity_or_process', 'GO_SO_EXT:frameshift_entity_or_process', 'GO_SO_EXT:frameshift_entity_or_process', 'GO_SO_EXT:frameshift_entity_or_process', 'PR_EXT:000004122', 'CHEBI_PR_EXT:protein', 'SO_EXT:0000673', 'SO_EXT:0000147', 'GO_SO_EXT:frameshift_entity_or_process', 'GO_SO_EXT:frameshift_entity_or_process', 'GO_SO_EXT:frameshift_entity_or_process', 'GO_SO_EXT:frameshift_entity_or_process', 'SO_EXT:0001587', 'SO_EXT:0001587', 'SO_EXT:0001587', 'SO_EXT:0001587', 'SO_EXT:sequence_truncation_process', 'CHEBI_SO_EXT:polypeptide', 'CHEBI_SO_EXT:amino_acid', 'CHEBI_SO_EXT:amino_acid']
17002498	46	['Southern blot analysis of tail DNA from F1 offspring of both ApcCKON and ApcΔ580 lines confirmed the germline transmission of modified Apc allele (Figure 1B).']	(8169, 8327)	['CHEBI_SO_EXT:DNA', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'CHEBI_SO_EXT:DNA', 'SO_EXT:sequence_alteration_process', 'SO_EXT:0001023', 'UBERON:0002415']
17002498	47	['Mice that are heterozygous for ApcΔ580 mutation are viable but have a significantly reduced lifespan (Figure 1C).']	(8328, 8441)	['NCBITaxon:10088', 'PR_EXT:000004122', 'SO_EXT:sequence_alteration_entity_or_process', 'UBERON:0000104']
17002498	48	['These results suggested that deletion of exon 14 indeed results in either loss or abnormal function of the Apc gene product.']	(8442, 8566)	['PR_EXT:000004122', 'SO_EXT:sequence_deletion_entity_or_process', 'SO_EXT:0000147', 'SO_EXT:gene_product', 'SO_EXT:gene_product']
17002498	49	['ApcΔ580/+ mice have median survival of 5 mo of age (Figure 1C), with progressive signs of rectal bleeding and anemia.']	(8567, 8684)	['NCBITaxon:10088', 'PR_EXT:000004122', 'SO_EXT:normal_or_wild_type_or_present', 'UBERON:0001052']
17002498	50	['Similar to the results reported with an independently generated ApcΔ580/+ conditional mouse strain [14], ApcΔ580/+ mice had more than 100 (120 ± 37, n = 11) intestinal tumors at the time of their death (Figure S1).']	(8685, 8899)	['GO:0016265', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:normal_or_wild_type_or_present', 'UBERON:0000160']
17002498	51	['Inactivation of wild-type Apc is an important prerequisite for tumor development.']	(8900, 8981)	['PR_EXT:000004122', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality']
17002498	52	['We analyzed 30 intestinal tumors from ApcΔ580/+ mice by in vitro transcription and translation assay, but none of them showed truncated Apc products (unpublished data), indicating that the most likely mechanism of wild-type Apc inactivation is by allelic loss.']	(8982, 9242)	['GO_EXT:transcription', 'GO:0006412', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:sequence_truncation_process', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:0001023', 'UBERON:0000160']
17002498	53	['The mutant allele had to be maintained and transmitted through male mice, as ApcΔ580/+ females were frequently not healthy enough to successfully nurse their own pups because of their tumor burden.']	(9243, 9440)	['GO:0001967', 'NCBITaxon:10088', 'NCBITaxon_UBERON_EXT:pup', 'PR_EXT:000004122', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:0001023', 'SO_EXT:normal_or_wild_type_or_present', 'PATO_UBERON_EXT:male_or_bearer_of_maleness', 'PATO_UBERON_EXT:female_or_bearer_of_femaleness', 'NCBITaxon_UBERON_EXT:pup']
17002498	54	['ApcCKO/+ mice were intercrossed to generate ApcCKO/CKO offspring.']	(9442, 9507)	['NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:normal_or_wild_type_or_present']
17002498	55	['Approximately one-quarter of the offspring (17 of 81) were homozygous for the ApcCKO allele.']	(9508, 9600)	['PR_EXT:000004122', 'SO_EXT:0001023']
17002498	56	['These mice as well as heterozygous mice for ApcCKO allele are normal, showing no differences in their survival to the wild-type littermates (Figure 1C).']	(9601, 9753)	['NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122', 'SO_EXT:0001023', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality']
17002498	57	['We tested whether our ApcCKO allele can compliment the wild-type allele by crossing the ApcCKO/CKO female with ApcΔ580/+ male mouse.']	(9754, 9886)	['NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:0001023', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:0001023', 'SO_EXT:normal_or_wild_type_or_present', 'PATO_UBERON_EXT:female_or_bearer_of_femaleness', 'PATO_UBERON_EXT:male_or_bearer_of_maleness']
17002498	58	['The resultant ApcCKO/Δ580 offspring were viable and born in the Mendelian ratio, suggesting that the presence of loxP sites in introns flanking exon 14 have no adverse effect on the function of the Apc gene.']	(9887, 10094)	['GO:0007567', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:0000346', 'SO_EXT:0000346', 'SO_EXT:0000188', 'SO:0000357', 'SO_EXT:0000147', 'SO_EXT:0000704']
17002498	59	['K14-Driven Loss of Apc Results in Severe Growth Retardation and Early Lethality\n\nTo introduce the mutation of Apc into cells expressing K14, we crossed WW6 ES cell–derived [15] ApcCKO/+ mice with K14-cre recombinase mice in FVB background [16].']	(10096, 10340)	['CL_GO_EXT:cell', 'CL:0002322', 'CL:0002322', 'GO_EXT:biological_growth_entity_or_process', 'GO_EXT:fatality_or_lethality', 'GO:0010467', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO_EXT:recombinase', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000009454', 'SO_EXT:sequence_alteration_entity_or_process', 'SO_EXT:normal_or_wild_type_or_present']
17002498	60	['The K14-cre; ApcCKO/+ mice were normal in appearance and were fertile.']	(10341, 10411)	['NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000004122', 'SO_EXT:normal_or_wild_type_or_present']
17002498	61	['K14-cre; ApcCKO/+ males were crossed to ApcCKO/CKO females to avoid the potential deleter effect in oocytes of K14-cre–positive females [17].']	(10412, 10553)	['CL:0000023', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000009454', 'SO_EXT:normal_or_wild_type_or_present', 'PATO_UBERON_EXT:male_or_bearer_of_maleness', 'PATO_UBERON_EXT:female_or_bearer_of_femaleness', 'PATO_UBERON_EXT:female_or_bearer_of_femaleness']
17002498	62	['The mice were intercrossed thereafter for maintenance; hence, the mice used for analysis were in a mixed background of FVB, 129/S, and C57BL/6 in similar proportions, with minimal contribution of SJ.']	(10554, 10753)	['NCBITaxon:10088', 'NCBITaxon:10088']
17002498	63	['The K14 promoter is a commonly used epidermal cell promoter because of its expression by the mitotically active cells of the epidermis and its appendages in mature skin [18], but most notably it is active in embryonic ectoderm as early as the single layered ectodermal stage of embryonic day (E) 9.5 [19].']	(10755, 11060)	['CL:0000362', 'CL:0000362', 'CL:0000362', 'CL:0000362', 'CL:0000362', 'GO:0010467', 'GO:0007067', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000009454', 'SO_EXT:0000167', 'SO_EXT:0000167', 'UBERON:0007376', 'UBERON:0007376', 'UBERON:0004529', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0000924', 'UBERON:0000924', 'UBERON:0000924', 'UBERON:0000922']
17002498	64	['A restricted expression of K14 is also found in thymic epithelial cells (TECs) in the medulla of normal thymus [20].']	(11061, 11177)	['CL:0002293', 'CL:0002293', 'CL:0002293', 'CL:0002293', 'GO:0010467', 'CL_GO_EXT:cell', 'PR_EXT:000009454', 'UBERON:0003846', 'UBERON:0003846', 'UBERON:0002124', 'UBERON:0002124', 'UBERON:0002124']
17002498	65	['We genotyped a total of 458 pups (8–10 d old) from 67 litters resulting from crosses between K14-cre; ApcCKO/+ and ApcCKO/CKO mice.']	(11179, 11310)	['NCBITaxon_UBERON_EXT:pup', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:normal_or_wild_type_or_present', 'NCBITaxon_UBERON_EXT:pup']
17002498	66	['The mutant mice of the genotype K14-cre; ApcCKO/CKO (hereafter, KA mutant) were born, but the observed frequency of KA mutants was much less than expected (78 of 458 [17.0%]; p < 0.0005 Chi-square analysis, Table 1).']	(11311, 11527)	['GO:0007567', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000004122', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:genotype_or_entity_with_genotype', 'SO_EXT:sequence_altered_entity', 'SO_EXT:sequence_altered_entity']
17002498	67	['To assess the basis for the neonatal lethality of KA mutants, we monitored three litters from birth to weaning by measuring the body weight of each pup every day.']	(11528, 11690)	['GO_EXT:fatality_or_lethality', 'GO:0007567', 'NCBITaxon_UBERON_EXT:pup', 'SO_EXT:sequence_altered_entity', 'PATO_UBERON_EXT:neonate_or_newborn', 'UBERON_EXT:body', 'NCBITaxon_UBERON_EXT:pup']
17002498	68	['A total of 25 pups were born from three litters, of which 7 (28%) were confirmed to be K14-cre; ApcCKO/CKO by genotyping, indicating that KA mutants were born in the expected Mendelian ratio.']	(11691, 11882)	['GO:0007567', 'GO:0007567', 'NCBITaxon_UBERON_EXT:pup', 'PR_EXT:000009454', 'PR_EXT:000004122', 'SO_EXT:sequence_altered_entity', 'NCBITaxon_UBERON_EXT:pup']
17002498	69	['The KA mutant pups were nursed normally, and there was milk in their stomachs during the first 2 or 3 d after birth, but they failed to thrive (Figure 2).']	(11883, 12037)	['GO:0001967', 'GO:0007567', 'NCBITaxon_UBERON_EXT:pup', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'NCBITaxon_UBERON_EXT:pup', 'UBERON:0001913', 'UBERON:0000945']
17002498	70	['By postnatal day (P) 8–10, at the time of genotyping, many KA mutant pups were considerably smaller than their littermates (Figure 2B–2F) and some have died at or prior to this age.']	(12038, 12219)	['GO:0007567', 'GO:0016265', 'NCBITaxon_UBERON_EXT:pup', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'NCBITaxon_UBERON_EXT:pup']
17002498	71	['None of KA mutants survived to weaning age.']	(12220, 12263)	['SO_EXT:sequence_altered_entity']
17002498	72	['The ability of whole embryos to exclude blue dye was used to examine the epidermal barrier, normally acquired beginning at E16 and complete by E18.5 [21].']	(12265, 12419)	['CHEBI_EXT:37958', 'UBERON:0000922', 'UBERON:0007376']
17002498	73	['Analyses of E17.5–E18.5 KA mutants showed that they were able to exclude blue dye, indicating that the epidermal barrier was intact (Figure S2).']	(12420, 12564)	['CHEBI_EXT:37958', 'SO_EXT:sequence_altered_entity', 'UBERON:0007376']
17002498	74	['At these embryonic ages, there were no differences in size between the mutants and their littermates, but the mutants showed a patch of “birthmark” or dark pigmentation on their foreheads and a dark median line that ran caudally from head to tail.']	(12565, 12812)	['GO_PATO_EXT:biological_pigmentation_process_or_quality', 'SO_EXT:sequence_altered_entity', 'SO_EXT:sequence_altered_entity', 'UBERON:0000922', 'UBERON:0008200', 'UBERON:0000033', 'UBERON:0002415']
17002498	75	['Their external ears or pinnae were shriveled in appearance and pigmented compared to those of littermates.']	(12813, 12919)	['CHEBI_EXT:26130', 'UBERON:0001691', 'UBERON:0001691', 'UBERON:0001757']
17002498	76	['External characteristics of KA mutants that were evident at E18.5 persisted after birth and became more prominent as they grew (Figure 2A–2F).']	(12921, 13063)	['GO:0007567', 'GO:0040007', 'SO_EXT:sequence_altered_entity']
17002498	77	['Growth of pelage hair was generally delayed in the mutants.']	(13064, 13123)	['GO_EXT:biological_growth_entity_or_process', 'SO_EXT:sequence_altered_entity', 'UBERON:0010509', 'UBERON:0010509']
17002498	78	['At around P8, the KA mutants were hairless and had wrinkled skin while their phenotypically normal littermates had a smooth thin coat of hair (Figure 2B).']	(13124, 13278)	['SO_EXT:sequence_altered_entity', 'UBERON:0001037', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0010166', 'UBERON:0010166', 'UBERON:0010166']
17002498	79	['At this age, two lower incisors start to erupt in normal littermates and these were absent in the KA mutants (Figure 2C and 2D).']	(13279, 13407)	['SO_EXT:sequence_altered_entity', 'UBERON:0003451', 'UBERON:0003451']
17002498	80	['Animals also tended to be smaller and around P10–P12 displayed abnormally short and misshapen vibrissae and short, shaggy pelage hairs (Figure 2C and 2D).']	(13408, 13562)	['NCBITaxon:33208', 'UBERON:0006378', 'UBERON:0010509', 'UBERON:0010509']
17002498	81	['Development of thick ridges in their skin, particularly around the ears, eyelids, forehead, nose, and paws, became noticeable (Figure 2E).']	(13563, 13701)	['UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0001690', 'UBERON:0001711', 'UBERON:0008200', 'UBERON:0000004', 'UBERON_EXT:paw']
17002498	82	['These regions looked scaly, and these animals hardly kept their eyes open.']	(13702, 13776)	['NCBITaxon:33208', 'UBERON:0000970']
17002498	83	['In contrast to the normal littermates that consistently increased their body weight with age, surviving KA mutants started to lose weight from P10 onwards; by P16–P17 they were all lethargic, and none of them survived to weaning (Figure 2E and 2F).']	(13777, 14025)	['SO_EXT:sequence_altered_entity', 'UBERON_EXT:body']
17002498	84	['At the time of autopsy all the mutants were toothless, without incisors or molars, and their stomachs were consistently small and had no solid food, unlike their age-matched littermates, suggesting that the observed weight loss could be the result of failure to ingest solid food (Figure 2F).']	(14026, 14318)	['CHEBI_EXT:33290', 'CHEBI_EXT:33290', 'GO:0007631', 'SO_EXT:sequence_altered_entity', 'UBERON:0001091', 'UBERON:0001098', 'UBERON:0003655', 'UBERON:0000945']
17002498	85	['Interestingly, changes in body weights and timing of hair growth varied considerably among mutant pups even if they were from the same litter, whereas those of phenotypically normal littermates tended to be similar.']	(14319, 14534)	['GO_EXT:biological_growth_entity_or_process', 'NCBITaxon_UBERON_EXT:pup', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON_EXT:body', 'UBERON:0001037', 'NCBITaxon_UBERON_EXT:pup']
17002498	86	['This difference was also reflected in the variation in timing of death in mutants: some mutant pups were born alive but died within a day or two, some survived close to the weaning age.']	(14535, 14720)	['GO:0016265', 'GO:0007567', 'GO:0016265', 'NCBITaxon_UBERON_EXT:pup', 'SO_EXT:sequence_altered_entity', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'NCBITaxon_UBERON_EXT:pup']
17002498	87	['This variability of the mutant phenotypes suggests possible variation in the timing and efficiency of cre-mediated Apc deletion.']	(14721, 14849)	['PR_EXT:000004122', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:sequence_deletion_entity_or_process']
17002498	88	['It is possible that the genetic background has a role to play in this variability.']	(14850, 14932)	['SO_EXT:0000704']
17002498	89	["Gross examination of internal organs also showed that the mutants' thymi were consistently inconspicuous and were very small for their age, whereas those of their littermates were very prominent in size (Figure 2G)."]	(14934, 15149)	['SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0000062', 'UBERON:0002370']
17002498	90	['This difference was evident as early as P3.']	(15150, 15193)	[]
17002498	91	['Quite frequently mutant thymi in P12–P17 mutant mice also contained black deposits within the tissue (unpublished data).']	(15194, 15314)	['NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370', 'UBERON:0000479']
17002498	92	['Mutant mice were also examined for any skeletal abnormalities by preparing skeletal specimens of P16–P17 mice stained with Alizarin red.']	(15315, 15451)	['CHEBI:16866', 'CHEBI:16866', 'NCBITaxon:10088', 'NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0004288', 'UBERON:0004288']
17002498	93	['No differences between the normal and KA mutant mice in the mandibular bone can be detected, but the mutant mice lacked or had underdeveloped set of maxillary incisors and molars (Figure 2H).']	(15452, 15643)	['NCBITaxon:10088', 'NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0001684', 'UBERON:0001684', 'UBERON:0003666', 'UBERON:0003450', 'UBERON:0003450', 'UBERON:0003666']
17002498	94	['We detected no other major skeletal abnormalities.']	(15644, 15694)	['UBERON:0004288']
17002498	95	['Genotype- and Tissue-Specific Expression of the Truncated Apc Transcripts\n\nTo assess the molecular effects of the K14-cre–mediated recombination, we screened for the presence of deleted Apc (ApcΔ580) alleles.']	(15696, 15904)	['CHEBI_EXT:polyatomic_entity_or_group', 'GO:0010467', 'GO_SO_EXT:sequence_rearrangement_process', 'PR_EXT:000004122', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:genotype_or_entity_with_genotype', 'SO_EXT:sequence_truncation_process', 'SO_EXT:0000673', 'GO_SO_EXT:sequence_rearrangement_process', 'SO_EXT:sequence_deletion_process', 'SO_EXT:0001023', 'UBERON:0000479']
17002498	96	['Genomic DNA was extracted from liver, thymus, and skin from all 4 possible genotypes: K14-cre; ApcCKO/CKO, K14-cre; ApcCKO/+, ApcCKO/CKO, and ApcCKO/+.']	(15905, 16056)	['CHEBI_SO_EXT:DNA', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:genomic_DNA', 'SO_EXT:genomic_DNA', 'SO_EXT:genotype_or_entity_with_genotype', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:normal_or_wild_type_or_present', 'UBERON:0002107', 'UBERON:0002370', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	97	['Genotyping on genomic DNA from these tissues showed that the ApcΔ580 allele (500-bp product) was detected only from the skin and thymus of the K14-cre–positive mice.']	(16057, 16222)	['CHEBI_SO_EXT:DNA', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000009454', 'SO_EXT:genomic_DNA', 'SO_EXT:genomic_DNA', 'SO_EXT:0001023', 'SO_EXT:0000028', 'UBERON:0000479', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0002370']
17002498	98	['The presence of mutant Apc allele in the thymus of K14-cre; ApcCKO/+ mice was consistently much less than the DNA from the skin of the same animal or other tissues from the KA mutants.']	(16223, 16407)	['CHEBI_SO_EXT:DNA', 'NCBITaxon:10088', 'NCBITaxon:33208', 'PR_EXT:000004122', 'PR_EXT:000009454', 'PR_EXT:000004122', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:0001023', 'SO_EXT:normal_or_wild_type_or_present', 'CHEBI_SO_EXT:DNA', 'SO_EXT:sequence_altered_entity', 'UBERON:0002370', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0000479']
17002498	99	['In addition, this product was not detected at all in either the liver of K14-cre–positive or in any of the K14-cre–negative mouse tissues samples, establishing that Cre-mediated recombination has taken place in the tissue-specific manner in the mice that inherited K14-cre (Figure 3A).']	(16408, 16693)	['GO_SO_EXT:sequence_rearrangement_process', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000009454', 'PR_EXT:000009454', 'GO_SO_EXT:sequence_rearrangement_process', 'UBERON:0002107', 'UBERON:0000479', 'UBERON:0000479']
17002498	100	['Apc transcripts were also analyzed by RT-PCR with primers spanning exon 14 (Figure 1A) using total RNA isolated from the corresponding tissue samples.']	(16695, 16845)	['CHEBI_SO_EXT:RNA', 'GO_EXT:reverse_transcription_or_reverse_transcriptase', 'GO_EXT:reverse_transcription_or_reverse_transcriptase', 'PR_EXT:000004122', 'SO_EXT:0000673', 'SO_EXT:0000112', 'SO_EXT:0000147', 'CHEBI_SO_EXT:RNA', 'UBERON:0000479']
17002498	101	['We detected the expected RT-PCR product (313 bp) from the truncated Apc (ApcΔ580) allele only in the tissues where Cre recombinase is known to be expressed in the K14-cre–positive mice.']	(16846, 17031)	['GO_EXT:reverse_transcription_or_reverse_transcriptase', 'GO:0010467', 'GO_EXT:reverse_transcription_or_reverse_transcriptase', 'GO_EXT:recombinase', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000009454', 'SO_EXT:0000006', 'SO_EXT:0000006', 'SO_EXT:0000028', 'SO_EXT:sequence_truncation_process', 'SO_EXT:0001023', 'UBERON:0000479']
17002498	102	['However, this product was not detected in either the K14-cre–negative mouse tissues samples or the liver of K14-cre–positive mice, and only the product from the wild-type allele (528 bp) was detected from these RNA samples, further confirming that Cre-mediated recombination has taken place in the tissue- and genotype-specific manner (Figure 3B).']	(17032, 17379)	['CHEBI_SO_EXT:RNA', 'GO_SO_EXT:sequence_rearrangement_process', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000009454', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:0001023', 'SO_EXT:0000028', 'CHEBI_SO_EXT:RNA', 'GO_SO_EXT:sequence_rearrangement_process', 'SO_EXT:genotype_or_entity_with_genotype', 'UBERON:0000479', 'UBERON:0002107', 'UBERON:0000479']
17002498	103	['K14-cre–Driven Apc Loss Induced Aberrant Hair Follicles throughout the Epidermis\n\nTo understand the basis for delayed and abnormal hair development in the KA mutants, we conducted a histological and immunohistochemical examination (Figure 4).']	(17381, 17623)	['PR_EXT:000009454', 'PR_EXT:000004122', 'SO_EXT:sequence_altered_entity', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0007376', 'UBERON:0001037']
17002498	104	['The hair follicle is an epidermal appendage that consists of an upper permanent portion, and a lower cycling portion that produces the hair [22,23].']	(17624, 17772)	['UBERON:0002073', 'UBERON:0002073', 'UBERON:0007376', 'UBERON:0004529', 'UBERON:0001037']
17002498	105	['The outer root sheath (ORS) is contiguous with and biochemically similar to the basal layer of the epidermis.']	(17773, 17882)	['CHEBI_EXT:biochemical', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0002025', 'UBERON:0002025', 'UBERON:0002025', 'UBERON:0002025']
17002498	106	['The inner layers of the hair follicle include three concentric layers of inner root sheath and three concentric layers of hair-producing cells.']	(17883, 18026)	['CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0005941', 'UBERON:0005941', 'UBERON:0005941', 'UBERON:0001037']
17002498	107	['At the base of the hair follicle is the germinative hair follicle bulb, which contains rapidly proliferating “matrix” cells that differentiate to populate all of the layers of the inner root sheath and the hair shaft itself [22].']	(18027, 18256)	['CL_GO_EXT:cell', 'GO:0008283', 'GO_RO_EXT:developmental_differentiation_process', 'CL_GO_EXT:cell', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0005932', 'UBERON:0005932', 'UBERON:0005932', 'UBERON:0005941', 'UBERON:0005941', 'UBERON:0005941', 'UBERON:0002074', 'UBERON:0002074']
17002498	108	['During the anagen phase of the hair cycle (until P15), hair follicles of phenotypically normal mice grew deeply into the subcutaneous fat and were uniformly spaced and aligned in parallel arrays at a specific angle relative to the skin surface (Figure 4A).']	(18257, 18513)	['CHEBI_UBERON_EXT:triglyceride_or_adipose_tissue', 'GO:0042640', 'GO:0042640', 'GO:0042640', 'GO:0042640', 'GO:0042640', 'GO:0040007', 'NCBITaxon:10088', 'UBERON:0001037', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0002190', 'UBERON:0002190', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	109	['In contrast, KA mutant follicles were irregularly spaced and often seen as disoriented and clamped invaginations at P3 that became even more remarkable at P12 when the mutant mice were covered by fur coat (Figure 4F).']	(18514, 18731)	['NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON_EXT:follicle', 'UBERON:0010166']
17002498	110	['Bulbs were often bent in addition to being irregularly angled to one another and their sizes and locations were often variable.']	(18732, 18859)	[]
17002498	111	['Clusters of multiple invaginations or dysplastic follicular structures were frequently observed throughout the epidermis, whereas other regions showed gaps with no follicles.']	(18860, 19034)	['UBERON_EXT:follicle', 'UBERON:0007376', 'UBERON_EXT:follicle']
17002498	112	['Serial sectioning indicated that some of the hair follicles in the P12 mutant skin were not properly formed or shorter than normal.']	(19035, 19166)	['SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002073', 'UBERON:0002073', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	113	['Taken together, these features could account for the apparently delayed, followed by outgrowth, of the short and shaggy-looking fur coat of these mutant mice.']	(19167, 19325)	['NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0010166']
17002498	114	['Apc is a regulator of β-catenin that is important for Wnt signaling.']	(19327, 19395)	['GO_EXT:regulator', 'GO:0016055', 'GO:0016055', 'PR_EXT:000004122', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198']
17002498	115	['We examined the patterns of expression of β-catenin in the affected tissues.']	(19396, 19472)	['GO:0010467', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'UBERON:0000479']
17002498	116	['In the normal skin, β-catenin, a member of the adherens junction complex, was found in the ORS of hair follicles and basal layer of epidermis, where K14 expression is also observed (Figure 4C and 4D), whereas the expression of K1, involucrin, and loricrin (markers for spinous and granular layers of epidermis) was only observed in the nonbasal epidermis (unpublished data).']	(19473, 19847)	['CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'GO:0010467', 'GO:0010467', 'GO:0005912', 'GO:0005912', 'GO:0005912', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009454', 'PR_EXT:000009450', 'PR_EXT:000009167', 'PR_EXT:000009882', 'CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0002025', 'UBERON:0002025', 'UBERON:0002025', 'UBERON:0002025', 'UBERON:0002026', 'UBERON:0002069', 'UBERON:0002069', 'UBERON:0002026', 'UBERON:0002069', 'UBERON:0002026', 'UBERON:0002069', 'UBERON:0002026', 'UBERON:0007376']
17002498	117	['The patterns of expression of K14, K1, involucrin, and loricrin, in skin from mutant and normal littermate mice at P3–P17, showed no significant differences in the terminal differentiation (Figure 4A–4D, 4F–4I).']	(19848, 20059)	['GO:0010467', 'GO_RO_EXT:developmental_differentiation_process', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000009450', 'PR_EXT:000009167', 'PR_EXT:000009882', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	118	['Similarly, the pattern of expression of K6, which is normally only expressed in the suprabasal or inner layer of the ORS of the hair follicle but not in the epidermis (Figure 4E), did not change.']	(20060, 20255)	['GO:0010467', 'GO:0010467', 'PR_EXT:keratin_6', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0007376']
17002498	119	['Due to the abnormal and disorganized structure of hair follicles themselves, K6 localization highlighted the histological abnormality (Figure 4J).']	(20256, 20402)	['GO_PATO_EXT:biological_localization_process_or_quality', 'PR_EXT:keratin_6', 'UBERON:0002073', 'UBERON:0002073']
17002498	120	['Yet as in the normal skin, K6 was principally seen only in the suprabasal layer of the ORS that did not colocalize with the basal markers, K14 or K5 (Figure 4I and 4J).']	(20403, 20571)	['CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'GO_PATO_EXT:biological_localization_process_or_quality', 'PR_EXT:keratin_6', 'PR_EXT:000009454', 'PR_EXT:000009481', 'CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0005942']
17002498	121	['In normal skin, proliferating cells were detected in either the basal layer of epidermis or in germinative hair follicle bulbs at the base (Figure 4B).']	(20573, 20724)	['CL_GO_EXT:cell', 'GO:0008283', 'CL_GO_EXT:cell', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0002025', 'UBERON:0002025', 'UBERON:0002025', 'UBERON:0002025', 'UBERON:0005932', 'UBERON:0005932', 'UBERON:0005932']
17002498	122	['In the mutant skin, either BrdU incorporation or Ki67 expression was observed not only in cells in bulbs at the base of the hair follicle but also in bulb-like structures that were budding out from the ORS of the existing hair follicles (Figure 4G and 4G′).']	(20725, 20982)	['CHEBI:472552', 'CL_GO_EXT:cell', 'GO:0010467', 'CL_GO_EXT:cell', 'PR_EXT:000010425', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0005942']
17002498	123	['Each budding tip was becoming like a hair follicle bulb containing proliferating cells.']	(20983, 21070)	['CL_GO_EXT:cell', 'GO:0008283', 'CL_GO_EXT:cell', 'UBERON:0005932', 'UBERON:0005932', 'UBERON:0005932']
17002498	124	['Hence, despite the abnormal histology in the mutant skin, proliferation seems to be confined to bulb-like structures as in the normal skin (Figure 4G and 4G′).']	(21071, 21230)	['GO:0008283', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	125	['The exact locations of hair follicle bulbs were not as easy to define for some mutant follicles due to their disorganized structures.']	(21231, 21364)	['SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0005932', 'UBERON:0005932', 'UBERON:0005932', 'UBERON_EXT:follicle']
17002498	126	['Interestingly, in the mutant skin, in addition to diffuse membrane-bound localization as in the normal skin, cells with strong cytosolic β-catenin localization were also observed frequently (Figure 4H and 4H′).']	(21365, 21575)	['CL_GO_EXT:cell', 'GO_PATO_EXT:biological_localization_process_or_quality', 'GO_PATO_EXT:biological_localization_process_or_quality', 'GO:0016020', 'CL_GO_EXT:cell', 'GO:0005829', 'CHEMINF_GO_EXT:chemical_binding_or_bond_formation', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	127	['These elevated β-catenin–expressing cells were usually surrounded by proliferating cells, forming bulb-like structures.']	(21576, 21695)	['CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO:0010467', 'GO:0008283', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198']
17002498	128	['Comparison of immunochemically stained serial sections showed that these intense cytosolic β-catenin stainings were usually found in either K14-positive K1-negative basal epidermis or K14-positive K6-negative basal ORS cells, and are surrounded by proliferating cells.']	(21696, 21964)	['CL:0000646', 'CL:0002561', 'CL:0002561', 'CL:0000646', 'CL_GO_EXT:cell', 'GO:0008283', 'GO:0005829', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009454', 'PR_EXT:000009450', 'PR_EXT:000009454', 'PR_EXT:keratin_6', 'UBERON:0002025', 'UBERON:0002025', 'UBERON:0005942']
17002498	129	['To determine the initiation of hair follicle morphogenesis in these mutants, we examined the expression pattern of Sonic hedgehog (Shh), a factor expressed in hair bulbs in embryonic skin (Figure 5).']	(21966, 22165)	['GO:0031069', 'GO:0031069', 'GO:0031069', 'GO:0010467', 'GO:0010467', 'PR_EXT:000014841', 'PR_EXT:000014841', 'PR_EXT:000014841', 'SO_EXT:sequence_altered_entity', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0005932', 'UBERON:0005932', 'UBERON:0000922', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	130	['The aberrant hair follicle morphogenesis is evident as early as E14.5 in mutant embryonic skin, by multiple apolarized expression of Shh throughout the epidermis (Figure 5B), whereas that of control embryos was well polarized and regularly spaced (Figure 5A).']	(22166, 22425)	['GO:0031069', 'GO:0031069', 'GO:0031069', 'GO:0010467', 'PR_EXT:000014841', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0000922', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0007376', 'UBERON:0000922']
17002498	131	['With development, control mouse hair follicles invaginate downward in a polarized manner (Figure 5C), whereas those of mutant embryos were completely irregular and apolarized (Figure 5D).']	(22426, 22613)	['NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0000922']
17002498	132	['It was also noted that the size of each “budding” follicle, as detected by Shh expression, was variable (Figure 5D).']	(22614, 22730)	['GO:0010467', 'PR_EXT:000014841', 'UBERON_EXT:follicle']
17002498	133	['The intensity of Shh staining was generally stronger in mutant skin than in the normal skin.']	(22731, 22823)	['PR_EXT:000014841', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	134	['The aberrant initiation of multiple hair placodes during early hair follicle morphogenesis was also evident by the whole-mount in situ hybridization (ISH) of E15.5 mutant embryos for β-catenin (Figure 5F and 5F′).']	(22824, 23037)	['GO:0031069', 'GO:0031069', 'GO:0031069', 'GO:0097617', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0005086', 'UBERON:0005086', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0000922']
17002498	135	['The expression pattern of β-catenin in embryos clearly demonstrated the formation of regular arrays of hair placodes in the normal embryonic skin (Figure 5E and 5E′), but such regular patterning was lost, and often tightly clustered abnormal hair placodes were initiated in mutant embryonic skin (Figure 5F′).']	(23038, 23347)	['GO:0010467', 'GO_PATO_EXT:biological_patterning_process_or_quality', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0000922', 'UBERON:0005086', 'UBERON:0005086', 'UBERON:0000922', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0005086', 'UBERON:0005086', 'UBERON:0000922', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	136	['Aberrant hair placodes were also evident throughout the skin surface of limbs in E15.5 mutants (Figure 5F), whereas those of the control embryos had not yet formed (Figure 5E).']	(23348, 23524)	['SO_EXT:sequence_altered_entity', 'UBERON:0005086', 'UBERON:0005086', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0002101', 'UBERON:0000922']
17002498	137	['Most interestingly, in the mutant footpads, where hair placodes do not normally form (Figure 5G), we also found ectopic irregularly sized and spaced hair placodes, indicating that the footpads still have the potential to form hair placodes in the absence of the Apc gene (Figure 5H).']	(23525, 23808)	['PR_EXT:000004122', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:0000704', 'UBERON:0013623', 'UBERON:0005086', 'UBERON:0005086', 'UBERON:0005086', 'UBERON:0005086', 'UBERON:0013623', 'UBERON:0005086', 'UBERON:0005086']
17002498	138	['These results collectively suggest that the terminal differentiation does take place normally in the mutant skin, but initiation of embryonic hair follicle morphogenesis is severely disrupted, accompanied by a continuous ectopic hair follicle morphogenesis in postnatal mutant skin.']	(23810, 24092)	['GO_RO_EXT:developmental_differentiation_process', 'GO:0048598', 'GO:0031069', 'GO:0031069', 'GO:0031069', 'GO:0048598', 'GO:0031069', 'GO:0031069', 'GO:0031069', 'GO:0007567', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0000922', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0002073', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	139	['Effects of K14-cre–Driven Loss of Apc in Other Epidermal Appendages\n\nSimilar to the biology of hair follicles, K14-cre–driven loss of Apc also affected the development of other epidermal appendages that depend on epithelial–mesenchymal interactions for their formation.']	(24094, 24363)	['CHEBI_GO_EXT:biological_process_or_quality_or_role', 'CHEBI_GO_EXT:biological_process_or_quality_or_role', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000009454', 'PR_EXT:000004122', 'UBERON:0007376', 'UBERON:0004529', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0007376', 'UBERON:0004529', 'UBERON:0000483', 'UBERON:0003104']
17002498	140	['The most striking of these was dental dysplasia (Figure 4K–4R).']	(24364, 24427)	['UBERON:0001091']
17002498	141	['Tooth development is normally initiated between E11 and E12 by invagination of ectodermally derived oral epithelium into the underlying cranial neural crest–derived mesenchyme, generating a tooth germ.']	(24428, 24629)	['UBERON:0001091', 'UBERON:0000924', 'UBERON:0002424', 'UBERON:0002424', 'UBERON:0007213', 'UBERON:0007213', 'UBERON:0007213', 'UBERON:0007213', 'UBERON:0007213', 'UBERON:0007213', 'UBERON:0001091']
17002498	142	['Despite the grossly toothless phenotype of KA mutants, histological analysis of their oral cavities revealed the formation of multiple tooth buds at each location.']	(24630, 24793)	['SO_EXT:sequence_altered_entity', 'UBERON:0001091', 'UBERON:0000167', 'UBERON:0000167', 'UBERON:0008281', 'UBERON:0008281']
17002498	143	['These aberrant teeth obviously failed to grow out during the dietary transition from milk to solid food.']	(24794, 24898)	['CHEBI_EXT:33290', 'GO:0040007', 'UBERON:0001091', 'UBERON:0001913']
17002498	144	['Analogous to the expression patterns of K14 and β-catenin in the normal skin, diffuse membrane-bound expression of β-catenin was detected in K14-expressing oral epithelium and ameloblasts of normal mice.']	(24899, 25102)	['CL:0000059', 'GO:0010467', 'GO:0010467', 'GO:0010467', 'GO:0016020', 'CHEMINF_GO_EXT:chemical_binding_or_bond_formation', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009454', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0002424', 'UBERON:0002424']
17002498	145	['In mutants, some of the K14-expressing cells also showed strong cytosolic/nuclear β-catenin staining, as observed in the mutant skin (Figure 4Q, 4Q′, and 4R).']	(25103, 25261)	['CL_GO_EXT:cell', 'GO:0010467', 'CL_GO_EXT:cell', 'GO:0005829', 'GO:0005634', 'PR_EXT:000009454', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'SO_EXT:sequence_altered_entity', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	146	['Initiation of ectopic tooth buds in the mutant mice was evident at E15.5 by extra dots of Shh expression adjacent to the primary teeth (data not shown).']	(25262, 25414)	['GO:0010467', 'NCBITaxon:10088', 'PR_EXT:000014841', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0008281', 'UBERON:0008281', 'UBERON:0007115', 'UBERON:0007115']
17002498	147	['Loss of Apc also leads to hyperplasia in squamous epithelia of cornea, oral, salivary, and Hardarian glands (unpublished data).']	(25416, 25543)	['PR_EXT:000004122', 'UBERON:0006914', 'UBERON:0006914', 'UBERON:0001772', 'UBERON:0004809', 'UBERON:0004694', 'UBERON:0001772', 'UBERON:0004809', 'UBERON:0004694', 'UBERON:0001772', 'UBERON:0010047', 'UBERON:0004809', 'UBERON:0004694', 'UBERON:0004809', 'UBERON:0004694', 'UBERON:0010047']
17002498	148	['Squamous metaplasia to hair follicle–like structures, ectopic hair follicle morphogenesis was also observed in these epithelia.']	(25544, 25671)	['GO:0031069', 'GO:0031069', 'GO:0031069', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0000483']
17002498	149	['K14-cre–Driven Apc Loss Results in Hypoplastic/Athymic Mice\n\nThymus is an organ that is also known to have K14 expression [16].']	(25673, 25800)	['GO:0010467', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000009454', 'UBERON:0002370', 'UBERON:0002370', 'UBERON:0000062']
17002498	150	['It represents the primary lymphoid organ for thymocyte development and selection.']	(25801, 25882)	['CL_UBERON_EXT:lymphocyte_or_lymphoid_progenitor_or_system_or_tissue', 'CL:0000893', 'CL_UBERON_EXT:lymphocyte_or_lymphoid_progenitor_or_system_or_tissue', 'UBERON:0000062']
17002498	151	['Distinct population of TECs of cortex and medulla mediates both of these critical functions.']	(25883, 25975)	['CL:0002364', 'CL:0002365', 'CL:0002364', 'CL:0002365', 'CL:0002364', 'CL:0002365', 'UBERON:0001851', 'UBERON:0000958']
17002498	152	['Cortical and medullary TEC subsets are characterized by differential expression of four keratin species: K8, K18, K5, and K14.']	(25976, 26102)	['CL:0002364', 'CL:0002365', 'CL:0002364', 'CL:0002365', 'GO:0010467', 'PR_EXT:000009495', 'PR_EXT:000009458', 'PR_EXT:000009481', 'PR_EXT:000009454', 'UBERON:0001851', 'UBERON:0000958']
17002498	153	['The normal thymus is a lobulated lymphoid organ, each lobule clearly showing the two distinct TEC compartments, an outer cortex and an inner medulla (Figure 6).']	(26104, 26264)	['CL_UBERON_EXT:lymphocyte_or_lymphoid_progenitor_or_system_or_tissue', 'CL:0002293', 'UBERON:0002370', 'CL_UBERON_EXT:lymphocyte_or_lymphoid_progenitor_or_system_or_tissue', 'UBERON:0000062', 'UBERON:0009911', 'UBERON:0001851', 'UBERON:0000958']
17002498	154	['There were no major differences in the histology of thymus between the ages P3 to P17 in phenotypically normal littermates.']	(26265, 26388)	['UBERON:0002370']
17002498	155	['As shown in the H&E staining of thymus, the cortex was formed of dense lymphoid tissue that lacks nodules (Figure 6A).']	(26389, 26507)	['CHEBI:51686', 'CHEBI_EXT:eosin', 'CL_UBERON_EXT:lymphocyte_or_lymphoid_progenitor_or_system_or_tissue', 'UBERON:0002370', 'UBERON:0001851', 'UBERON:0001744', 'UBERON:0001744']
17002498	156	['Since the stroma of the medulla is less heavily infiltrated with lymphocytes than the cortex, the medulla stained more lightly than the cortex.']	(26508, 26651)	['CL:0000542', 'UBERON:0003891', 'UBERON:0000958', 'UBERON:0001851', 'UBERON:0000958', 'UBERON:0001851']
17002498	157	['In normal mice, the thymus retains its size until the young adult age and regresses thereafter by atrophy.']	(26652, 26758)	['GO:0060033', 'NCBITaxon:10088', 'UBERON:0002370', 'UBERON:0007023']
17002498	158	['In the normal young mice we examined (P3–P17), it is evident that thymocytes were mitotically active in the cortex as determined by BrdU immunostaining (Figure 6B).']	(26759, 26923)	['CHEBI:472552', 'CL:0000893', 'GO:0007067', 'NCBITaxon:10088', 'UBERON:0001851']
17002498	159	["Immunohistochemistry of normal thymus from P3 to P17 mice showed a similar staining pattern for K14 in that its expression was restricted to a small population of TECs in the inner medullary region and in the keratinocytes in Hassall's corpuscles (Figure 6D)."]	(26924, 27183)	['CL:0002293', 'CL:0000312', 'GO:0010467', 'NCBITaxon:10088', 'PR_EXT:000009454', 'UBERON:0002370', 'UBERON:0000958', 'UBERON:0003987', 'UBERON:0003987', 'UBERON:0003987', 'UBERON:0003987']
17002498	160	['Diffuse cytoplasmic staining for β-catenin was also detected in the medullary epithelial cells (Figure 6C).']	(27184, 27291)	['CL:0000066', 'CL:0000066', 'GO:0005737', 'CL_GO_EXT:cell', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'UBERON:0000958', 'UBERON:0000483']
17002498	161	['In contrast to K14 expression, diffuse staining for K8 was observed in epithelial cells both in the medulla and cortex (Figure S3).']	(27292, 27423)	['CL:0000066', 'CL:0000066', 'GO:0010467', 'CL_GO_EXT:cell', 'PR_EXT:000009454', 'PR_EXT:000009495', 'UBERON:0000483', 'UBERON:0000958', 'UBERON:0001851']
17002498	162	["K1 staining was not detected in young mice at P3 but in older mice it was detected in differentiated keratinocytes in some of Hassall's corpuscles (Figure S3)."]	(27424, 27583)	['CL:0000312', 'GO_PATO_RO_EXT:developmental_differentiation_process_or_quality', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000009450', 'UBERON:0003987', 'UBERON:0003987', 'UBERON:0003987', 'UBERON:0003987']
17002498	163	['The histological abnormalities of thymus were evident as early as P3 in KA mutants (Figure 6E and 6H).']	(27585, 27687)	['SO_EXT:sequence_altered_entity', 'UBERON:0002370']
17002498	164	['The thymus was made of two lobules as in the normal mice but the mutant thymus was significantly smaller in size than that of the age-matched controls (Figure 2G).']	(27688, 27851)	['NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370', 'UBERON:0009911', 'UBERON:0002370']
17002498	165	['Interestingly, variations in the phenotypic severity of the mutant pups at P3 were prominently reflected in the extent of histological abnormalities of thymus.']	(27852, 28011)	['NCBITaxon_UBERON_EXT:pup', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'NCBITaxon_UBERON_EXT:pup', 'UBERON:0002370']
17002498	166	['A P3 KA mutant pup that showed milder phenotype with a comparable body weight to its normal littermates (Figure 2A, M2) showed milder thymus abnormalities (Figure 6E) compared to its more severe mutant littermate (Figure 2A, M1; Figure 6H).']	(28012, 28252)	['NCBITaxon_UBERON_EXT:pup', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'NCBITaxon_UBERON_EXT:pup', 'UBERON_EXT:body', 'UBERON:0002370']
17002498	167	['The milder P3 mutant thymus was already much smaller in size compared to those of normal littermates (data not shown) but two epithelial compartments of thymus were histologically still distinguishable, with colonization of thymocytes evident in the cortex.']	(28253, 28510)	['CL:0000893', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370', 'UBERON:0000483', 'UBERON:0002370', 'UBERON:0001851']
17002498	168	['However, there were small populations of lightly stained cells by H&E extending from the edge of the outer cortex towards inner medulla (Figure 6E), and these cells showed intense nuclear β-catenin staining whereas the rest of the medullary cells showed diffuse β-catenin staining pattern similar to that of the control (Figure 6F).']	(28511, 28843)	['CHEBI:51686', 'CHEBI_EXT:eosin', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO:0005634', 'CL_GO_EXT:cell', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'UBERON_EXT:cell_clump_or_cluster_or_group_or_mass_or_population', 'UBERON_EXT:cell_clump_or_cluster_or_group_or_mass_or_population', 'UBERON_EXT:cell_clump_or_cluster_or_group_or_mass_or_population', 'UBERON:0001851', 'UBERON:0000958', 'UBERON:0000958']
17002498	169	['Localization of K14 was limited to a few cells in the medulla and some overlapped with K8 localization (Figure 6G).']	(28844, 28959)	['CL_GO_EXT:cell', 'GO_PATO_EXT:biological_localization_process_or_quality', 'GO_PATO_EXT:biological_localization_process_or_quality', 'CL_GO_EXT:cell', 'PR_EXT:000009454', 'PR_EXT:000009495', 'UBERON:0000958']
17002498	170	['In the other P3 mutant thymus the distinct thymic epithelial compartments have been lost completely, and only a few lymphocytes were remaining at the edges and some in the middle (Figure 6H).']	(28961, 29152)	['CL:0000542', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370', 'UBERON:0003846', 'UBERON:0003846']
17002498	171	['Proliferative activities were no longer observed in thymocytes as prominently as in the normal thymus, but the epithelial cells seemed to be forming concentric structures (Figure 6I).']	(29153, 29336)	['CL:0000893', 'CL:0000066', 'CL:0000066', 'GO_PATO_EXT:cell_proliferation_or_proliferativity', 'CL_GO_EXT:cell', 'UBERON:0002370', 'UBERON:0000483']
17002498	172	['Unlike in the normal or mild mutant thymi, the severe P3 mutant thymus showed extensive K14 expression that overlapped with K8 expression (Figure 6K).']	(29337, 29487)	['GO:0010467', 'GO:0010467', 'PR_EXT:000009454', 'PR_EXT:000009495', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370', 'UBERON:0002370']
17002498	173	['These cells were more like basal cells of the skin than TECs and were adjacent to the most immature looking cells that were showing strong nuclear and cytoplasmic β-catenin staining (Figure 6J).']	(29488, 29682)	['CL_GO_EXT:cell', 'CL:0000646', 'CL:0000646', 'CL:0002293', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO:0005634', 'GO:0005737', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	174	['The nuclear staining of β-catenin was not observed in the normal age-matched thymus (Figure 6C).']	(29683, 29779)	['GO:0005634', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'UBERON:0002370']
17002498	175	['Most notably, the K14 and β-catenin staining patterns were mutually exclusive (Figure 6J and 6K).']	(29780, 29877)	['PR_EXT:000009454', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198']
17002498	176	["At P10–P13, the mutant thymus consisted of numerous enlarged Hassall's corpuscle–like structures, made of arrays of K14- and K8-expressing keratinizing epithelial cells surrounding large keratin deposits (Figure 6L and 6O)."]	(29879, 30102)	['CL:0000311', 'CL:0000066', 'CL:0000066', 'CL:0000311', 'GO:0010467', 'GO:0031424', 'CL_GO_EXT:cell', 'PR_EXT:000009454', 'PR_EXT:000009495', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370', 'UBERON:0003987', 'UBERON:0003987', 'UBERON:0003987', 'UBERON:0003987', 'UBERON:0000483']
17002498	177	['There were numerous neutrophils and macrophages infiltrating the thymus in response to these keratins; hence, these structures could be called pyogranuloma.']	(30103, 30259)	['CL:0000775', 'CL:0000235', 'GO_EXT:reaction_or_response', 'UBERON:0002370']
17002498	178	["Varying degrees of differentiation-specific markers depending on the age of mice, in this case K1 and involucrin that are normally present only in Hassall's corpuscles, were also detected in mutant thymi (Figure S3)."]	(30260, 30476)	['CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'GO_RO_EXT:developmental_differentiation_process', 'NCBITaxon:10088', 'PR_EXT:000009450', 'PR_EXT:000009167', 'CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0003987', 'UBERON:0003987', 'UBERON:0003987', 'UBERON:0003987', 'UBERON:0002370']
17002498	179	['In these mice no thymocytes were detectable.']	(30477, 30521)	['CL:0000893', 'NCBITaxon:10088']
17002498	180	['BrdU incorporation was only observed in very few keratinizing epithelial cells, looking somewhat similar to the pattern of mature skin (Figure 6M).']	(30522, 30669)	['CHEBI:472552', 'CL:0000311', 'CL:0000066', 'CL:0000066', 'CL:0000311', 'GO:0031424', 'CL_GO_EXT:cell', 'UBERON:0000483', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	181	['The diffuse expression of β-catenin was also present in these epithelial cells, and at this age fewer cells were positive for nuclear β-catenin staining (Figure 6N).']	(30670, 30835)	['CL:0000066', 'CL:0000066', 'CL_GO_EXT:cell', 'GO:0010467', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'GO:0005634', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'UBERON:0000483']
17002498	182	['As in the younger mutant mice, however, nuclear localization of β-catenin was only observed in K14-negative cells that looked like undifferentiated basal cells.']	(30836, 30996)	['CL_GO_EXT:cell', 'CL:0000646', 'CL:0000646', 'GO_PATO_EXT:biological_localization_process_or_quality', 'GO_PATO_RO_EXT:developmental_differentiation_process_or_quality', 'GO:0005634', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'NCBITaxon:10088', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009454', 'SO_EXT:sequence_altered_entity_or_alteration_process']
17002498	183	['In older P17 mice, the histopathology and keratin expression pattern of the mutant thymus was similar to that of P13 except for the fact that β-catenin expression became increasingly diffuse and appeared to colocalize with K8/K14 expression (data not shown).']	(30997, 31255)	['GO:0010467', 'GO:0010467', 'GO_PATO_EXT:biological_localization_process_or_quality', 'GO:0010467', 'NCBITaxon:10088', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009495', 'PR_EXT:000009454', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370']
17002498	184	['This coincided with fewer immature cells in the older mutant thymus.']	(31256, 31324)	['CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370']
17002498	185	['Collectively, these results suggest that loss of Apc and consequent stabilization of β-catenin in K14-expressing TECs lead to their aberrant proliferation and differentiation to keratinocytes, causing massive squamous metaplasia, rather than to form either medullary or cortical TECs.']	(31326, 31610)	['CL:0002293', 'CL:0000312', 'CL:0002365', 'CL:0002364', 'CL:0002365', 'CL:0002364', 'GO:0010467', 'GO:0008283', 'GO:0030216', 'GO:0030216', 'GO:0030216', 'PR_EXT:000004122', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009454', 'UBERON:0000958', 'UBERON:0001851']
17002498	186	['Loss of proper TEC compartments consequently resulted in loss of thymocytes for maturation and the mice to be “athymic.”\n\nDiscussion\n\nApc is implicated in the Wnt signaling pathway that is involved both in development and tumorigenesis.']	(31611, 31847)	['CL:0002293', 'CL:0000893', 'GO_PATO_EXT:biological_maturation', 'GO:0016055', 'GO:0016055', 'GO:0016055', 'NCBITaxon:10088', 'PR_EXT:000004122', 'UBERON:0002370']
17002498	187	['Human germline mutations in APC cause FAP [4,5], which is characterized by hundreds of adenomatous colorectal polyps, with an almost inevitable progression to colorectal cancer in the third and fourth decades of life.']	(31848, 32065)	['NCBITaxon:9606', 'PR_EXT:000004122', 'SO_EXT:sequence_alteration_entity_or_process', 'UBERON:0012652', 'UBERON:0012652', 'UBERON:0000104']
17002498	188	["The phenotypical features of FAP and its variant, Gardner's syndrome, can be very variable."]	(32066, 32157)	[]
17002498	189	['As well as colorectal polyps, these individuals can develop extracolonic symptoms, among which are upper gastrointestinal tract polyps, congenital hypertrophy of the retinal pigment epithelium, desmoid tumors, disorders of the maxillary and skeletal bones, and dental abnormalities [6].']	(32158, 32444)	['CHEBI_EXT:26130', 'NCBITaxon:1', 'UBERON:0012652', 'UBERON:0001155', 'UBERON:0004908', 'UBERON:0004908', 'UBERON:0004908', 'UBERON:0001782', 'UBERON:0001782', 'UBERON:0001782', 'UBERON:0002397', 'UBERON:0004288', 'UBERON:0001474', 'UBERON:0001091']
17002498	190	['While the heterozygous knockout mice for Apc develop adenomatous polyps predominantly in small intestine, the homozygous embryos die before gastrulation.']	(32445, 32598)	['GO:0016265', 'GO:0007369', 'NCBITaxon:10088', 'PR_EXT:000004122', 'UBERON:0002108', 'UBERON:0002108', 'UBERON:0000922']
17002498	191	['To gain more insights into the effects of Apc loss in tissues other than gastrointestinal tract during life of animals and to circumvent the embryonic lethality associated with Apc nullizygosity, we created a mouse strain carrying a conditional allele of Apc (ApcCKO) in which exon 14 of the Apc is flanked by loxP sequences.']	(32599, 32924)	['GO_EXT:fatality_or_lethality', 'NCBITaxon:33208', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:0001023', 'SO_EXT:0000147', 'SO:0000357', 'SO_EXT:0000346', 'SO_EXT:0000346', 'UBERON:0000479', 'UBERON:0001555', 'UBERON:0001555', 'UBERON:0000104', 'UBERON:0000922']
17002498	192	['The homozygous mice for the conditional allele are viable and indistinguishable to the normal mice, allowing us to study the roles of Apc in a tissue- and temporal-specific manner.']	(32925, 33105)	['NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122', 'SO_EXT:0001023', 'UBERON:0000479']
17002498	193	['To assess the phenotypic consequences of inactivation of the Apc gene in cells that express K14, we created mice that are homozygous for the ApcCKO allele and contain a K14-cre transgene.']	(33107, 33294)	['CL_GO_EXT:cell', 'GO:0010467', 'CL_GO_EXT:cell', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000009454', 'SO_EXT:0000704', 'SO_EXT:0001023', 'SO_EXT:0000902']
17002498	194	['These mice failed to thrive and died before weaning.']	(33295, 33347)	['GO:0016265', 'NCBITaxon:10088']
17002498	195	['They also exhibited hair, tooth, and thymus phenotypes.']	(33348, 33403)	['UBERON:0001037', 'UBERON:0001091', 'UBERON:0002370']
17002498	196	['Apc and Hair Follicle Morphogenesis\n\nCurrent models of hair follicle development suggest that the establishment of a regular array of placodes in the surface epithelium in response to the first dermal message is achieved through the competing activities of molecules that promote or repress placode fate [24].']	(33405, 33714)	['CHEBI:36357', 'GO:0031069', 'GO:0031069', 'GO:0031069', 'GO:0001942', 'GO:0001942', 'GO:0001942', 'GO_EXT:reaction_or_response', 'PR_EXT:000004122', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0002073', 'UBERON_EXT:placode', 'UBERON:0000483', 'UBERON_EXT:skin_or_dermis', 'UBERON_EXT:placode']
17002498	197	['There is accumulating evidence that activation of the Wnt signaling pathway in the dermis may be involved in establishing the first dermal signal.']	(33715, 33861)	['GO:0016055', 'GO:0016055', 'GO:0016055', 'UBERON:0002067', 'UBERON_EXT:skin_or_dermis']
17002498	198	['Experimental activation of epithelial β-catenin signaling (by expression of N-terminal–truncated, constitutively stabilized forms of β-catenin or ectopic expression of Lef1) induces ectopic follicles in both mouse and chick skin [25–27].']	(33862, 34099)	['CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO:0010467', 'GO:0010467', 'NCBITaxon:10088', 'NCBITaxon_UBERON_EXT:chick', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009751', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'SO_EXT:sequence_truncation_process', 'UBERON:0000483', 'UBERON_EXT:follicle', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	199	['Conversely, down-regulation of β-catenin signaling (through Lef1 knock-out, ectopic expression of Wnt inhibitor Dkk1 or conditional deletion of β-catenin in epidermis) results in loss of vibrissae and some pelage follicles in mice [28–30].']	(34100, 34339)	['CHEBI_EXT:35222', 'GO_EXT:negative_regulation', 'GO_EXT:negative_regulation', 'GO_EXT:negative_regulation', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO:0010467', 'NCBITaxon:10088', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009751', 'PR_EXT:000006499', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'SO_EXT:sequence_deletion_entity_or_process', 'UBERON:0007376', 'UBERON:0010419', 'UBERON:0010509', 'UBERON_EXT:follicle']
17002498	200	['Our finding that K14-driven Apc loss in embryonic ectoderm resulted in irregularly spaced and often tightly clustered abnormal hair placode initiation and follicle morphogenesis (Figures 4F, 5B, 5D, and 5F) as well as in the development of multiple tooth buds (Figure 4O and 4P), is in line with the effects seen in activation of epithelial β-catenin signaling during placode formation, indicating the role of Apc in specification of embryonic ectodermal stem cells to produce a hair follicle.']	(34340, 34833)	['CL:0002322', 'CL:0000221', 'CL:0002322', 'CL:0000221', 'CL:0002322', 'GO:0009653', 'GO_EXT:cell_communication_or_signaling_or_signal_transduction', 'GO:0048866', 'GO:0001715', 'GO:0048866', 'GO:0001715', 'GO:0001715', 'GO:0048866', 'GO:0048866', 'GO:0001715', 'CL_GO_EXT:cell', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000004122', 'UBERON:0000924', 'UBERON:0000924', 'UBERON:0005086', 'UBERON:0005086', 'UBERON_EXT:follicle', 'UBERON:0008281', 'UBERON:0008281', 'UBERON:0000483', 'UBERON_EXT:placode', 'UBERON:0000924', 'UBERON:0000924', 'UBERON:0002073', 'UBERON:0002073']
17002498	201	['Given the role of Apc in down-regulation of β-catenin, loss of Apc would inevitably lead to altered expression of β-catenin in ectodermal cells during the hair placode formation, giving rise to aberrant follicular growth throughout the embryonic epidermis, including the footpads, where normally hairless (Figure 5B, 5D, 5F, and 5H).']	(34834, 35167)	['CL:0000221', 'CL:0000221', 'GO_EXT:negative_regulation', 'GO_EXT:negative_regulation', 'GO_EXT:negative_regulation', 'GO:0010467', 'GO:0060789', 'GO:0060789', 'GO:0060789', 'GO_EXT:biological_growth_entity_or_process', 'CL_GO_EXT:cell', 'PR_EXT:000004122', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000004122', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'UBERON:0000924', 'UBERON:0005086', 'UBERON:0005086', 'UBERON_EXT:follicle', 'UBERON:0000922', 'UBERON:0007376', 'UBERON:0013623', 'UBERON:0001037']
17002498	202	['Of interest are the phenotypic similarities and differences between our KA mutant mice and the previously described K14-ΔN87βcat transgenic mice expressing stable β-catenin under the control of K14 promoter [25] and K14-Lef1 transgenic mice [27].']	(35168, 35414)	['GO:0010467', 'GO:0065007', 'NCBITaxon:10088', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009454', 'PR_EXT:000009454', 'PR_EXT:000009751', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:transgenic_entity', 'SO_EXT:0000167', 'SO_EXT:transgenic_entity']
17002498	203	['Surprisingly, our mutant mice shared more similarities with the K14-Lef1 mice than the K14-ΔN87βcat transgenic mice.']	(35415, 35531)	['NCBITaxon:10088', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000009751', 'PR_EXT:000009454', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:transgenic_entity']
17002498	204	['For example, the KA mutant mice displayed the disoriented and short, curly whiskers seen in K14-Lef1but not in K14-ΔN87βcat transgenic mice.']	(35532, 35672)	['NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000009454', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:transgenic_entity']
17002498	205	['In addition, KA mutant mice displayed a disorganized hair coat beginning with the emergence of neonatal hairs, similar to that observed in K14-Lef1 mice, whereas in K14-ΔN87βcat mice, embryonic hair follicle morphogenesis was unaffected and other skin changes only emerged postnatally.']	(35673, 35958)	['GO:0048598', 'GO:0031069', 'GO:0031069', 'GO:0031069', 'GO:0048598', 'GO:0007567', 'NCBITaxon:10088', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000009751', 'PR_EXT:000009454', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0010166', 'UBERON:0010166', 'PATO_UBERON_EXT:neonate_or_newborn', 'UBERON:0001037', 'UBERON:0000922', 'UBERON:0002073', 'UBERON:0002073', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	206	['The reason for this difference could be attributed to one or all of three possible contributing factors.']	(35959, 36063)	[]
17002498	207	['(1) Although the K14 promoter itself is known to initiate the expression at E9.5 and elevated dramatically by E13.5–E14.5 [19,31], many factors could influence the expression of promoter/transgene construct in transgenic mice.']	(36064, 36290)	['GO:0010467', 'GO:0010467', 'NCBITaxon:10088', 'PR_EXT:000009454', 'SO_EXT:0000167', 'SO_EXT:0000167', 'SO_EXT:0000902', 'SO_EXT:engineered_biological_sequence', 'SO_EXT:transgenic_entity']
17002498	208	['One of the most important considerations has to do with the integration site of the transgene in the mouse genome.']	(36291, 36405)	['NCBITaxon:10088', 'SO_EXT:0000366', 'SO_EXT:0000366', 'SO_EXT:0000902', 'SO_EXT:0001026']
17002498	209	['Depending on the location of integration, the transcriptional activity of even the same transgene could vary considerably.']	(36406, 36528)	['GO_EXT:transcription', 'SO_EXT:0000366', 'SO_EXT:0000366', 'SO_EXT:0000366', 'SO_EXT:0000902']
17002498	210	['It is possible that the apparent lack of ΔN87βcat function in embryogenesis could be due to the delayed or weak expression of the K14-ΔN87βcat transgene compared to the intrinsic promoter.']	(36529, 36717)	['GO:0009790', 'GO:0010467', 'PR_EXT:000009454', 'SO_EXT:0000902', 'SO_EXT:0000167']
17002498	211	['In contrast, Cre-mediated recombination is seen in E13.5 skin of K14-cre transgenic mice used in this study [16] and K14-cre–mediated truncation of the Apc gene is likely to have occurred by then, in time for the second wave of hair follicle morphgenesis.']	(36718, 36973)	['GO_SO_EXT:sequence_rearrangement_process', 'GO:0031069', 'GO:0031069', 'GO:0031069', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000009454', 'PR_EXT:000004122', 'GO_SO_EXT:sequence_rearrangement_process', 'SO_EXT:transgenic_entity', 'SO_EXT:sequence_truncation_entity_or_process', 'SO_EXT:0000704', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0002073', 'UBERON:0002073']
17002498	212	['(2) Another important fact is that in the aforementioned transgenic model the overexpression of transgene is confined to the basal cells of the epidermis and the ORS of hair follicles, where the K14 promoter is active.']	(36974, 37192)	['CL:0002187', 'CL:0002187', 'CL:0002561', 'CL:0002187', 'CL:0002561', 'CL:0002187', 'CL:0002561', 'CL:0002561', 'CL:0002561', 'CL:0002561', 'GO:0010467', 'CL_GO_EXT:cell', 'PR_EXT:000009454', 'SO_EXT:transgenic_entity', 'SO_EXT:0000902', 'SO_EXT:0000167', 'UBERON:0007376', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0005942']
17002498	213	['The expression of transgene is hence transient and stops once K14-expressing cells terminally differentiate.']	(37193, 37301)	['CL_GO_EXT:cell', 'GO:0010467', 'GO:0010467', 'GO_RO_EXT:developmental_differentiation_process', 'CL_GO_EXT:cell', 'PR_EXT:000009454', 'SO_EXT:0000902']
17002498	214	['In contrast, in our model, K14-cre–mediated deletion of Apc would result in Apc mutation not only in K14 promoter active cells, but remain so in all cell layers that derived from the K14 promoter active progenitors.']	(37302, 37517)	['CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000009454', 'PR_EXT:000009454', 'SO_EXT:sequence_deletion_entity_or_process', 'SO_EXT:sequence_alteration_entity_or_process', 'SO_EXT:0000167', 'SO_EXT:0000167', 'UBERON:0000119', 'UBERON:0000119']
17002498	215	['These derivatives include the suprabasal epidermis and the entire epithelium of the hair follicle.']	(37518, 37616)	['UBERON:0010402', 'UBERON:0010402', 'UBERON:0000483', 'UBERON:0002073', 'UBERON:0002073']
17002498	216	['Stabilization of β-catenin in a broader population of cells could account for some of the phenotypic differences.']	(37617, 37730)	['CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'UBERON_EXT:cell_clump_or_cluster_or_group_or_mass_or_population', 'UBERON_EXT:cell_clump_or_cluster_or_group_or_mass_or_population', 'UBERON_EXT:cell_clump_or_cluster_or_group_or_mass_or_population']
17002498	217	['However, we did not detect any elevated β-catenin expression in either K1- or K6-positive differentiated cells in postnatal mutant skin.']	(37731, 37867)	['CL_GO_EXT:cell', 'GO:0010467', 'GO_PATO_RO_EXT:developmental_differentiation_process_or_quality', 'GO:0007567', 'CL_GO_EXT:cell', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009450', 'PR_EXT:keratin_6', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	218	['This indicates that despite the absence of Apc and potential stabilization of β-catenin in derivatives of K14-expressing progenitors, elevated β-catenin expression, and subsequent cell fate determination may only take place in basal cells.']	(37868, 38107)	['CL_GO_EXT:cell', 'CL:0000646', 'CL:0000646', 'GO:0010467', 'GO:0010467', 'GO:0001709', 'GO:0001709', 'GO:0001709', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000004122', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009454', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198']
17002498	219	['(3) We cannot exclude the possibility that given the multifunctional properties of Apc, disruption of its functions other than down-regulation of β-catenin may also have contributed to the observed overt phenotype.']	(38108, 38322)	['GO_EXT:negative_regulation', 'GO_EXT:negative_regulation', 'GO_EXT:negative_regulation', 'PR_EXT:000004122', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198']
17002498	220	['While some features of our mutant mice were similar to these transgenic mice, other phenotypic aspects were largely distinct.']	(38324, 38449)	['NCBITaxon:10088', 'NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:transgenic_entity']
17002498	221	['In addition to aberrant hair follicle morphogenesis, K14-driven loss of Apc caused formation of multiple tooth buds that, like hair follicles, were known to develop through inductive interactions between the epithelium and mesenchyme.']	(38450, 38684)	['GO:0031069', 'GO:0031069', 'GO:0031069', 'PR_EXT:000009454', 'PR_EXT:000004122', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0008281', 'UBERON:0008281', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0000483', 'UBERON:0003104']
17002498	222	['This observation was similar to the ectopic tooth buds found in animals misexpressing Lef1 [27], but more severe and was also present at birth, indicating the effect of Apc loss during the initiation of embryonic tooth development, which was evident by aberrant Shh expression in E15.5 embryonic oral epithelium (unpublished data).']	(38685, 39016)	['GO:0010467', 'GO:0007567', 'GO:0009790', 'GO:0009790', 'GO:0010467', 'NCBITaxon:33208', 'PR_EXT:000009751', 'PR_EXT:000004122', 'PR_EXT:000014841', 'UBERON:0008281', 'UBERON:0008281', 'UBERON:0000922', 'UBERON:0001091', 'UBERON:0000922', 'UBERON:0002424', 'UBERON:0002424']
17002498	223	['It should be noted that although multiple tooth buds were histologically visible (Figure 4O and 4P), these teeth never broke out and the KA mutant mice appeared toothless.']	(39017, 39188)	['NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0008281', 'UBERON:0008281', 'UBERON:0001091', 'UBERON:0001091']
17002498	224	['This unusual severe tooth defect is unique to these mutant mice.']	(39189, 39253)	['NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0001091']
17002498	225	['In addition, neither of the two transgenic mice was postnatally lethal as in the KA mutant mice.']	(39254, 39350)	['GO:0007567', 'GO_EXT:fatality_or_lethality', 'NCBITaxon:10088', 'NCBITaxon:10088', 'SO_EXT:transgenic_entity', 'SO_EXT:sequence_altered_entity_or_alteration_process']
17002498	226	['We did not find any obvious histopathological abnormalities in the internal organs of KA mice that could contribute to the lethality.']	(39351, 39484)	['GO_EXT:fatality_or_lethality', 'NCBITaxon:10088', 'UBERON:0000062']
17002498	227	['However, the fact that all the mutants had lower weight (Figure 2F) with hardly any evidence of solid food in their stomach indicates that the mutants might have died of starvation.']	(39485, 39666)	['CHEBI_EXT:33290', 'GO:0016265', 'SO_EXT:sequence_altered_entity', 'SO_EXT:sequence_altered_entity', 'UBERON:0000945']
17002498	228	['Dermal fat was reduced in the mutant skin, possibly as a consequence of poor nutrition caused by the absence of teeth.']	(39667, 39785)	['CHEBI_UBERON_EXT:triglyceride_or_adipose_tissue', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON_EXT:skin_or_dermis', 'CHEBI_UBERON_EXT:triglyceride_or_adipose_tissue', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0001091']
17002498	229	['Since the weight loss in KA mutants started from P8–P10 while pups were still nursed by their mothers, starvation due to lack of teeth cannot be the sole cause of death, but is likely to be a contributing factor.']	(39786, 39998)	['GO:0001967', 'GO:0016265', 'NCBITaxon_UBERON_EXT:pup', 'SO_EXT:sequence_altered_entity', 'NCBITaxon_UBERON_EXT:pup', 'UBERON:0001091']
17002498	230	['Absence of teeth and mammary glands have been observed in mice deficient in Lef1 and ectopically expressing Dkk1 [29,30] but their absence was due to the block in development before the bud stage.']	(39999, 40195)	['GO:0010467', 'NCBITaxon:10088', 'PR_EXT:000009751', 'PR_EXT:000006499', 'UBERON:0001091', 'UBERON:0001911', 'UBERON:0001911']
17002498	231	['Hence, neither loss nor excess of tooth bud formation allows proper development of teeth for mice to have a healthy diet and normal life.']	(40196, 40333)	['NCBITaxon:10088', 'UBERON:0008281', 'UBERON:0008281', 'UBERON:0001091', 'UBERON:0000104']
17002498	232	['Mechanistic studies to understand how increased levels of β-catenin leads to altered skin and tooth phenotypes are under way.']	(40334, 40459)	['PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0001091']
17002498	233	['Apc and Thymus Organogenesis\n\nIn this study, we observed that K14-driven loss of Apc resulted in a small thymus with severe squamous metaplasia leading to the formation of numerous pyogranuloma and loss of proper meshwork structure for thymocyte maturation, rendering the mice athymic.']	(40461, 40746)	['CL:0000893', 'GO:0048538', 'GO:0048538', 'GO_PATO_EXT:biological_maturation', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000009454', 'PR_EXT:000004122', 'UBERON:0002370', 'UBERON:0002370', 'UBERON:0002370']
17002498	234	['Previous studies have shown that in normal adult thymus K14 expression is found together with K5 in the stellate medullary TECs, but not in association with K5+ TECs in the cortex or at the cortico-medullary junction.']	(40747, 40964)	['CL:0002365', 'CL:0002365', 'CL:0002293', 'GO:0010467', 'PR_EXT:000009454', 'PR_EXT:000009481', 'PR_EXT:000009481', 'UBERON:0007023', 'UBERON:0002370', 'UBERON:0000958', 'UBERON:0001851', 'UBERON:0001851', 'UBERON:0000958']
17002498	235	['In addition, it has been demonstrated that K14+ TECs do not coexpress K8; hence, there are two distinct medullary subsets, namely a K8−K14+ stellate subset and a K8+K14− globular subset [32].']	(40965, 41156)	['CL:0002293', 'GO:0010467', 'PR_EXT:000009454', 'PR_EXT:000009495', 'PR_EXT:000009495', 'PR_EXT:000009454', 'PR_EXT:000009495', 'PR_EXT:000009454', 'UBERON:0000958']
17002498	236	['In agreement with the previous results, in P3 normal thymus K14 expression was restricted to stellate medullary TECs (Figure 6D), whereas K8 expression was found throughout the TECs (unpublished data).']	(41157, 41358)	['CL:0002365', 'CL:0002365', 'CL:0002293', 'GO:0010467', 'GO:0010467', 'PR_EXT:000009454', 'PR_EXT:000009495', 'UBERON:0002370', 'UBERON:0000958']
17002498	237	['We could not clarify whether these two keratins were coexpressed in the same TECs without double-staining.']	(41359, 41465)	['CL:0002293', 'GO:0010467']
17002498	238	['There were individual differences among mutants and these were prominently reflected in the histological abnormalities of the thymus at P3, but as the older surviving mutants all showed the same histopathologies of the thymus, the mutant thymi eventually seem to result in the same fate.']	(41466, 41753)	['SO_EXT:sequence_altered_entity', 'SO_EXT:sequence_altered_entity', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370', 'UBERON:0002370', 'UBERON:0002370']
17002498	239	['It is unclear when K14-cre induction actually takes place in the mutant thymus, but as the population of cells showing a strong nuclear β-catenin staining as well as the cells expressing K14 were small and thymic epithelial compartments still existed in a mild P3 mutant thymus (Figure 6E and 6F), it seems that initial differentiation to medullary and cortical TECs and thymocyte colonization have already taken place prior to the major effects of K14-driven Apc loss.']	(41754, 42223)	['CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL:0002365', 'CL:0002364', 'CL:0002365', 'CL:0002364', 'CL:0000893', 'GO:0010467', 'GO_RO_EXT:developmental_differentiation_process', 'CL_GO_EXT:cell', 'GO:0005634', 'CL_GO_EXT:cell', 'PR_EXT:000009454', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009454', 'PR_EXT:000009454', 'PR_EXT:000004122', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370', 'UBERON_EXT:cell_clump_or_cluster_or_group_or_mass_or_population', 'UBERON_EXT:cell_clump_or_cluster_or_group_or_mass_or_population', 'UBERON_EXT:cell_clump_or_cluster_or_group_or_mass_or_population', 'UBERON:0003846', 'UBERON:0003846', 'UBERON:0002370', 'UBERON:0000958', 'UBERON:0001851']
17002498	240	['However, cells with nuclear β-catenin and K8+K14+ double-positive epithelial cells increased subsequently, associated with active proliferation in the latter group of cells and loss of TEC compartments.']	(42224, 42426)	['CL_GO_EXT:cell', 'CL:0000066', 'CL:0000066', 'CL_GO_EXT:cell', 'CL:0002293', 'GO:0008283', 'CL_GO_EXT:cell', 'GO:0005634', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009495', 'PR_EXT:000009454', 'UBERON:0000483', 'UBERON_EXT:cell_clump_or_cluster_or_group_or_mass_or_population', 'UBERON_EXT:cell_clump_or_cluster_or_group_or_mass_or_population', 'UBERON_EXT:cell_clump_or_cluster_or_group_or_mass_or_population']
17002498	241	['With age, β-catenin expression pattern became more diffuse and fewer epithelial cells showed nuclear localization but K8+K14+ cells remained, forming concentric structures of epithelial cells filled with hard keratin deposits and infiltrated with vast number of neutrophils and macrophages.']	(42427, 42717)	['CL:0000066', 'CL:0000066', 'CL_GO_EXT:cell', 'CL:0000066', 'CL:0000066', 'CL:0000775', 'CL:0000235', 'GO:0010467', 'GO_PATO_EXT:biological_localization_process_or_quality', 'CL_GO_EXT:cell', 'GO:0005634', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009495', 'PR_EXT:000009454', 'UBERON:0000483', 'UBERON:0000483']
17002498	242	['Only a few epithelial cells were dividing and hardly any thymocytes were present by this time.']	(42718, 42812)	['CL:0000066', 'CL:0000066', 'CL:0000893', 'CL_GO_EXT:cell', 'UBERON:0000483']
17002498	243	['These results suggest that with the deletion of Apc in TECs, stabililization and nuclear localization of β-catenin took place and subsequently these cells differentiated into keratinocytes that expressed both K14 and K8, similar to the basal cells of the skin, instead of TEC subsets.']	(42813, 43097)	['CL:0002293', 'CL_GO_EXT:cell', 'CL:0000312', 'CL:0000646', 'CL:0000646', 'CL:0002293', 'GO_PATO_EXT:biological_localization_process_or_quality', 'GO_PATO_RO_EXT:developmental_differentiation_process_or_quality', 'GO:0010467', 'GO:0005634', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000004122', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009454', 'PR_EXT:000009495', 'SO_EXT:sequence_deletion_entity_or_process', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	244	['The expansion and differentiation of these keratinocytes lead to loss of proper thymic epithelial compartments and in turn produced and deposited the hard keratins that consequently caused vast amount of neutrophils and macrophages to infiltrate the thymus.']	(43098, 43355)	['CL:0000312', 'CL:0000775', 'CL:0000235', 'GO_RO_EXT:developmental_differentiation_process', 'UBERON:0003846', 'UBERON:0003846', 'UBERON:0002370']
17002498	245	['These aberrant epithelial structures eventually have overtaken the whole of the thymus and driven out the colonized thymocytes.']	(43356, 43483)	['CL:0000893', 'UBERON:0000483', 'UBERON:0002370']
17002498	246	['K14-driven loss of Apc and subsequent constitutive expression of β-catenin in TECs have therefore misdirected them to wrong epithelial cell fate, not allowing proper differentiation to either cortical or medullary TECs, which is essential for normal thymocyte development.']	(43484, 43756)	['CL:0002293', 'CL:0000066', 'CL:0000066', 'CL:0002364', 'CL:0002365', 'CL:0002365', 'CL:0002364', 'CL:0000893', 'GO:0010467', 'GO_EXT:biological_direction_or_guidance', 'GO_RO_EXT:developmental_differentiation_process', 'CL_GO_EXT:cell', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'UBERON:0000483', 'UBERON:0001851', 'UBERON:0000958']
17002498	247	['This is not only evident from the lack of dividing thymocytes in the mutant thymus by P13, but also by the differential expression pattern of keratins, which were more skin-like than TEC-like.']	(43757, 43949)	['CL:0000893', 'CL:0002293', 'GO:0010467', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	248	['The importance of Apc function in thymic development has been demonstrated by thymocyte-specific loss of Apc by crossing a different strain of Apc conditional mice and LckCre transgenic mice [33].']	(43950, 44146)	['CL:0000893', 'GO:0048538', 'GO:0048538', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:transgenic_entity', 'UBERON:0002370']
17002498	249	['Here, by K14-driven TEC-specific loss of Apc, we have demonstrated its importance in thymus development not only in thymocytes but also in TECs.']	(44147, 44291)	['CL:0002293', 'CL:0000893', 'CL:0002293', 'GO:0048538', 'GO:0048538', 'PR_EXT:000009454', 'PR_EXT:000004122', 'UBERON:0002370']
17002498	250	["It is of interest that dental abnormalities, such as supernumerary and impacted teeth similar to those observed in our mutant mice, are frequently seen in patients with Gardner's syndrome, carriers of APC germline mutation [6]."]	(44293, 44520)	['NCBITaxon:10088', 'PR_EXT:000004122', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:sequence_alteration_entity_or_process', 'UBERON:0001091', 'UBERON:0001091']
17002498	251	['The importance of odonto-stomatological examinations should hence be pointed out as a means of reaching a presumptive diagnosis, whose confirmation is vital to the patient.']	(44521, 44693)	['UBERON:0001091', 'UBERON:0000165']
17002498	252	['Further characterization of the mechanism of such developmental defects using our mouse model should provide important insights into Apc function in multiple organ systems and to give better insights into potential adverse events in human subjects.']	(44694, 44942)	['NCBITaxon:10088', 'NCBITaxon:9606', 'PR_EXT:000004122', 'UBERON:0000467', 'UBERON:0000467']
17002498	253	['In conclusion, we have shown that loss of Apc in K14-expressing embryonic cells causes aberrant morphogenesis in various skin appendages, including hair follicles and teeth, and abnormal thymus organogensis.']	(44944, 45151)	['CL:0002321', 'CL:0002321', 'GO:0010467', 'GO:0009653', 'GO:0048538', 'GO:0048538', 'CL_GO_EXT:cell', 'PR_EXT:000004122', 'PR_EXT:000009454', 'UBERON:0000922', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0004529', 'UBERON:0002073', 'UBERON:0002073', 'UBERON:0001091', 'UBERON:0002370']
17002498	254	['Our results provide genetic evidence that expression of Apc is essential for regulation of proper cell fates in these organs that require epithelial–mesenchymal interactions.']	(45152, 45326)	['CL_GO_EXT:cell', 'GO:0010467', 'GO:0065007', 'CL_GO_EXT:cell', 'PR_EXT:000004122', 'SO_EXT:0000704', 'UBERON:0000062', 'UBERON:0000483', 'UBERON:0003104']
17002498	255	['Materials and Methods\n\nConstruction of targeting vectors.']	(45328, 45385)	['SO_EXT:0001644', 'SO_EXT:0001644']
17002498	256	['To target the Apc locus, we obtained BAC clone RP23-233F17 that contains all the sequence of Apc except for the 5′ UTR and exon 1.']	(45387, 45517)	['PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:0000153', 'SO_EXT:sequence_cloned_entity', 'SO_EXT:biological_sequence', 'SO_EXT:0000204', 'SO_EXT:0000204', 'SO_EXT:0000204', 'SO_EXT:0000147']
17002498	257	['Using a recombineering-based method for generating conditional mutations [12,13], subcloning of BAC and further modifications were conducted.']	(45518, 45659)	['SO_EXT:sequence_alteration_entity_or_process', 'SO_EXT:0000153', 'SO_EXT:sequence_alteration_entity_or_process']
17002498	258	['The genomic sequence encompassing Apc exons 11 to 15 was first subcloned into pBR322 vector, and then a loxP site was introduced into intron 13 followed by loxP-FRT-PGKneor-FRT selection cassette into intron14 of the Apc gene (Figure 1A).']	(45660, 45898)	['CHEBI_GO_EXT:neomycin_or_neomycin_phosphotransferase', 'GO_EXT:0008910', 'GO_EXT:phosphoglycerate_kinase', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:0001026', 'SO_EXT:biological_sequence', 'SO_EXT:0000147', 'SO_EXT:0000440', 'SO_EXT:0000346', 'SO_EXT:0000346', 'SO_EXT:0000188', 'SO_EXT:0000346', 'SO_EXT:0000350', 'SO_EXT:0000350', 'SO_EXT:0005853', 'SO_EXT:0000704']
17002498	259	['Generation of ApcCKO ES cells and mice.']	(45900, 45939)	['CL:0002322', 'CL:0002322', 'GO:0048468', 'GO:0048468', 'GO:0048468', 'CL_GO_EXT:cell', 'NCBITaxon:10088', 'PR_EXT:000004122']
17002498	260	['The linearized targeting vectors were electroporated into 129/S-derived ES cells, WW6 cells [15].']	(45941, 46038)	['CL:0002322', 'CL:0002322', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'SO_EXT:sequence_linearization', 'SO_EXT:0001644', 'SO_EXT:0001644']
17002498	261	['All candidate G418-resistant ES clones were screened by long-range gene-specific PCR using Expand Long Template PCR System (Roche, Indianapolis, Indiana, United States), followed by sequencing to validate the correct insertion of the single loxP site and the selection cassette.']	(46039, 46317)	['CHEBI:42768', 'CL:0002322', 'SO_EXT:sequence_cloned_entity', 'SO_EXT:0000704', 'SO_EXT:sequence_insertion_entity_or_process', 'SO_EXT:0000346', 'SO_EXT:0000346', 'SO_EXT:0005853']
17002498	262	['Two ES clones with correct ApcCKON/+ modification were injected into C57BL/6J blastocysts, after which chimeric mice with high levels of ES cell contribution were backcrossed to C57BL/6J females to produce heterozygous F1 offspring.']	(46318, 46550)	['CL:0002322', 'CL:0002322', 'CL:0002322', 'CL_GO_EXT:cell', 'NCBITaxon:10088', 'PR_EXT:000004122', 'SO_EXT:sequence_cloned_entity', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:sequence_alteration_entity_or_process', 'UBERON:0000358', 'PATO_UBERON_EXT:female_or_bearer_of_femaleness']
17002498	263	['The genomic DNA samples obtained from the tail of F1 offspring were subsequently analyzed by Southern blot analysis to further confirm the correct homologous recombination.']	(46551, 46723)	['CHEBI_SO_EXT:DNA', 'GO_SO_EXT:sequence_rearrangement_process', 'SO_EXT:genomic_DNA', 'SO_EXT:genomic_DNA', 'GO_SO_EXT:sequence_rearrangement_process', 'UBERON:0002415']
17002498	264	['By crossing the heterozygous mice to FLPe deleter mice [34], PGKneor cassette was deleted in the germline by FRT-mediated recombination to generate mice with the final ApcCKO allele.']	(46724, 46906)	['CHEBI_GO_EXT:neomycin_or_neomycin_phosphotransferase', 'GO_SO_EXT:sequence_rearrangement_process', 'GO_EXT:0008910', 'GO_EXT:phosphoglycerate_kinase', 'NCBITaxon:10088', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122', 'SO_EXT:0005853', 'SO_EXT:sequence_deletion_process', 'SO_EXT:0000350', 'GO_SO_EXT:sequence_rearrangement_process', 'SO_EXT:0001023']
17002498	265	['ApcCKO heterozygous mice were crossed together to generate homozygous mice, and the homozygous offspring were interbred for maintenance.']	(46907, 47043)	['GO_EXT:breeding', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122']
17002498	266	['Generation of ApcΔ580 mice.']	(47045, 47072)	['NCBITaxon:10088', 'PR_EXT:000004122']
17002498	267	['ApcCKO heterozygote mice were crossed with Cre deleter mice, EIIA-cre transgenic mice that express Cre in early embryo [35], to knockout the Apc allele in the germline, consequently creating a knockout strain (Figure 1A).']	(47074, 47295)	['GO:0010467', 'NCBITaxon:10088', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:transgenic_entity', 'SO_EXT:0001023', 'UBERON:0019248', 'UBERON:0019248']
17002498	268	['The resultant ApcΔ580/+ mice were maintained by backcrossing to C57BL/6J females.']	(47296, 47377)	['NCBITaxon:10088', 'PR_EXT:000004122', 'SO_EXT:normal_or_wild_type_or_present', 'PATO_UBERON_EXT:female_or_bearer_of_femaleness']
17002498	269	['Generation of K14-cre; ApcCKO/CKO mice.']	(47379, 47418)	['NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000004122']
17002498	270	['The mice analyzed in this study were generated by crossing ApcCKO heterozygote mice of the F1 generation (C57BL/6J × 129/S background) with K14-cre transgenic mice (FVB background).']	(47420, 47601)	['NCBITaxon:10088', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000009454', 'SO_EXT:transgenic_entity']
17002498	271	['K14-cre; ApcCKO/+ male mice thus generated were then crossed with ApcCKO/CKO females to generate homozygous and heterozygous ApcCKO offspring either with or without K14-cre.']	(47602, 47775)	['NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000009454', 'SO_EXT:normal_or_wild_type_or_present', 'PATO_UBERON_EXT:male_or_bearer_of_maleness', 'PATO_UBERON_EXT:female_or_bearer_of_femaleness']
17002498	272	['The mice were intercrossed thereafter for maintenance.']	(47776, 47830)	['NCBITaxon:10088']
17002498	273	['Genotyping of mice.']	(47832, 47851)	['NCBITaxon:10088']
17002498	274	['Genomic DNA from tips of mouse tails obtained at ~10 d of age was genotyped in a single PCR reaction with the following primers: Apc-Int13F2 (GAGAAACCCTGTCTCGAAAAAA) and Apc-Int13R2 (AGTGCTGTTTCTATGAGTCAAC), resulting in 320-bp and 430-bp products from the wild-type and conditional ApcCKO allele, respectively.']	(47853, 48164)	['CHEBI_SO_EXT:DNA', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:genomic_DNA', 'SO_EXT:genomic_DNA', 'SO_EXT:0000112', 'SO_EXT:0000028', 'SO_EXT:0000028', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:0001023', 'UBERON:0010162', 'UBERON:0010162', 'UBERON:0010162']
17002498	275	['For the detection of Cre-mediated deleted Apc allele, ApcΔ580, the primer Apc-Int14R4 (TTGGCAGACTGTGTATATAAGC) in combination with Apc-Int13F2 resulted in 500-bp product.']	(48165, 48335)	['PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:sequence_deletion_process', 'SO_EXT:0001023', 'SO_EXT:0000112', 'SO_EXT:0000028']
17002498	276	['Primers Cre-F1 (TCCAATTTACTGACCGTACACC) and Cre-R1 (CCGACGATGAAGCATGTTTAG) were used for detection of cre transgene in the germline, resulting in 300-bp products.']	(48336, 48498)	['SO_EXT:0000112', 'SO_EXT:0000902', 'SO_EXT:0000028']
17002498	277	['Amplification was performed in a 25-μl volume containing 15 mM Tris-HCl (pH 8.3), 50 mM KCl, 2.5 mM MgCl2, 0.2 mM dNTP, 0.2μM of each primer, and 1.25 U of AmpliTaq Gold (Applied Biosystems, Foster City, California, United States).']	(48499, 48730)	['CHEBI:9754', 'CHEBI:17883', 'CHEBI:32588', 'CHEBI:6636', 'CHEBI_EXT:dNTP', 'CHEBI_EXT:gold', 'SO_EXT:0000112']
17002498	278	['The reactions were heated for 10 min at 94 °C to heat-activate the enzyme followed by 30 PCR cycles at 94 °C for 30 s, 58 °C for 30 s, and 72 °C for 45 s, followed by the final extension for 5 min at 72 °C.']	(48731, 48937)	['CHEBI_GO_SO_EXT:enzyme', 'CHEBI_GO_SO_EXT:enzyme', 'CHEBI_GO_SO_EXT:enzyme']
17002498	279	['Skin permeability assay.']	(48939, 48963)	['UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	280	['Unfixed and freshly isolated E18.5 embryos were rinsed in PBS and then submerged in X-gal reaction mix at pH 4.5 (100 mM NaPO4, 1.3 mM MgCl2, 3 mM K3Fe(CN)6, 3 mM K4Fe(CN)6, and 1 mg/ml X-gal) at room temperature overnight [36].']	(48965, 49193)	['CHEBI:75055', 'CHEBI:75055', 'CHEBI:75055', 'CHEBI:60004', 'CHEBI:37586', 'CHEBI:6636', 'CHEBI:30060', 'CHEBI:30060', 'CHEBI:30060', 'CHEBI:30060', 'CHEBI:30060', 'CHEBI:30059', 'CHEBI:30059', 'CHEBI:30059', 'CHEBI:30059', 'CHEBI:30059', 'CHEBI:75055', 'CHEBI:75055', 'CHEBI:75055', 'UBERON:0000922']
17002498	281	['At this pH in the absence of epidermal barrier, the solution penetrates epidermis and an endogenous β-galactosidase–like activity catalyzes production of a blue precipitate.']	(49194, 49367)	['CHEBI:75958', 'GO_EXT:0004565', 'GO_EXT:0004565', 'GO_EXT:0004565', 'GO_MOP_EXT:catalysis', 'GO_MOP_EXT:catalysis', 'UBERON:0007376', 'UBERON:0007376']
17002498	282	['After staining, embryos were washed twice in PBS, fixed overnight at 4 °C in 4% paraformaldehyde, and were photographed using a 35 mm Nikon digital camera.']	(49368, 49523)	['CHEBI_EXT:paraformaldehye', 'UBERON:0000922']
17002498	283	['Skeletal preparations.']	(49525, 49547)	['UBERON:0004288']
17002498	284	['The skinned and eviscerated bodies of the oldest surviving KA mutants (P16–P17) and their age-matched littermates were placed into 1% potassium hydroxide (KOH) for 5 d. The bodies were transferred into a fresh solution of 1% KOH containing a few drops of 0.5% alizarin red S (Sigma, St. Louis, Missouri, United States) and left for another 5 d. The stained bodies were stored in glycerin and viewed under a dissection microscope.']	(49549, 49978)	['CHEBI:32035', 'CHEBI:32035', 'CHEBI:32035', 'CHEBI:75958', 'CHEBI:32035', 'CHEBI:16866', 'CHEBI:16866', 'CHEBI:17754', 'GO_EXT:biological_movement_or_translocation_process', 'SO_EXT:sequence_altered_entity', 'UBERON_EXT:body', 'UBERON_EXT:body', 'UBERON_EXT:body']
17002498	285	['Analysis for tissue-specific recombination.']	(49980, 50023)	['GO_SO_EXT:sequence_rearrangement_process', 'GO_SO_EXT:sequence_rearrangement_process', 'UBERON:0000479']
17002498	286	['Genotype/tissue-specific recombination of the conditional allele was examined by both PCR and RT-PCR.']	(50025, 50126)	['GO_SO_EXT:sequence_rearrangement_process', 'GO_EXT:reverse_transcription_or_reverse_transcriptase', 'GO_EXT:reverse_transcription_or_reverse_transcriptase', 'SO_EXT:genotype_or_entity_with_genotype', 'GO_SO_EXT:sequence_rearrangement_process', 'SO_EXT:0001023', 'UBERON:0000479']
17002498	287	['DNA samples extracted from various tissues collected at the time of autopsy were examined by genotyping PCR as described.']	(50127, 50248)	['CHEBI_SO_EXT:DNA', 'CHEBI_SO_EXT:DNA', 'UBERON:0000479']
17002498	288	["RNA extracted from various tissue homogenates in Trizol reagent were examined for expression of wild-type and truncated Apc alleles by SuperScript One-Step RT-PCR with Platinum Taq (Invitrogen, Carlsbad, California, United States), following manufacturer's protocol."]	(50249, 50515)	['CHEBI_SO_EXT:RNA', 'CHEBI_EXT:33893', 'CHEBI_EXT:platinum', 'GO:0010467', 'GO_EXT:reverse_transcription_or_reverse_transcriptase', 'GO_EXT:reverse_transcription_or_reverse_transcriptase', 'PR_EXT:000004122', 'CHEBI_SO_EXT:RNA', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:sequence_truncation_process', 'SO_EXT:0001023', 'UBERON:0000479']
17002498	289	['Approximately 200 ng of total RNA from either skin, liver, or thymus from each genotype was reverse-transcribed using primers Apc-F546 (TGAGGAATTTGTCTTGGCGAG) and Apc-R721 (GCACTTCCCATGGCAATCATT), resulting in 528-bp and 313-bp products from the wild-type/ApcCKO alleles and ApcΔ580 allele, respectively.']	(50516, 50820)	['CHEBI_SO_EXT:RNA', 'GO:0001171', 'GO:0001171', 'GO:0001171', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'CHEBI_SO_EXT:RNA', 'SO_EXT:genotype_or_entity_with_genotype', 'SO_EXT:0000112', 'SO_EXT:0000028', 'SO_EXT:0000028', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:0001023', 'SO_EXT:0001023', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0002107', 'UBERON:0002370']
17002498	290	['BrdU labeling.']	(50822, 50836)	['CHEBI:472552', 'CHEBI_SO_EXT:molecular_label_or_mark_or_tag_process', 'CHEBI_SO_EXT:molecular_label_or_mark_or_tag_process']
17002498	291	['Mice were injected intraperitoneally with approximately 50 μg/g body weight of BrdU (Sigma) dissolved in PBS 2 h before their death.']	(50838, 50970)	['CHEBI:472552', 'GO:0016265', 'NCBITaxon:10088', 'UBERON:0001179', 'UBERON_EXT:body']
17002498	292	["Tissue samples were fixed in Bouin's and processed as described below."]	(50971, 51041)	['UBERON:0000479']
17002498	293	['Histological and immunochemical analysis.']	(51043, 51084)	[]
17002498	294	['Mutant mice and age-matching littermates were humanely killed at various ages by CO2 inhalation.']	(51086, 51182)	['CHEBI:16526', 'GO_EXT:killing', 'NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process']
17002498	295	["Mice were skinned and pieces of skin were either snap-frozen in liquid nitrogen or immediately homogenized in Trizol reagent and stored at −80 °C until molecular analysis, or fixed flat on a piece of paper towel in Bouin's solution for histological and immunohistochemical examinations."]	(51183, 51469)	['CHEBI_EXT:nitrogen', 'CHEBI_EXT:33893', 'CHEBI_EXT:polyatomic_entity_or_group', 'CHEBI:75958', 'NCBITaxon:10088', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	296	["The mice were then dissected for gross examination, various tissues were similarly collected for future molecular analyses, and then the whole body was fixed in Bouin's solution."]	(51470, 51648)	['CHEBI_EXT:polyatomic_entity_or_group', 'CHEBI:75958', 'NCBITaxon:10088', 'UBERON:0000479', 'UBERON:0000468', 'UBERON:0000468']
17002498	297	['The samples were then submitted to Rodent Histopathological Core for processing and histopathological examinations.']	(51649, 51764)	['NCBITaxon:9989']
17002498	298	['For immunohistochemistry, 5-μm paraffin-embedded tissue sections were deparafinized in xylene, followed by alcohol rehydration.']	(51766, 51893)	['CHEBI:27338', 'CHEBI:30879', 'UBERON:0000479']
17002498	299	['After quenching endogenous peroxidases in 3% H2O2 in methanol, the slides were rinsed in distilled water, and an antigen retrieval step was carried out in a microwave oven for a total of 10 min in preheated citrate buffer (pH 6.0).']	(51894, 52125)	['CHEBI:16240', 'CHEBI:17790', 'CHEBI:15377', 'CHEBI_EXT:59132', 'CHEBI_EXT:citrate', 'CHEBI_CHMO_EXT:buffer_solution', 'GO_EXT:0004601']
17002498	300	['The slides were then incubated with primary antibodies at room temperature overnight.']	(52126, 52211)	['GO:0042571']
17002498	301	['Antibodies used were β-catenin (BD Transduction Lab, San Diego, California, United States), keratins 1, 5, 6, 14, involucrin, loricrin (Covance, Berkeley, California, United States), keratin 8 (Abcam, Cambridge, United Kingdom), Ki67 (Vector Laboratories, Burlingame, California, United States) and BrdU (Roche).']	(52212, 52524)	['CHEBI:472552', 'GO:0009293', 'GO:0042571', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:keratin_6', 'PR_EXT:000009454', 'PR_EXT:000009481', 'PR_EXT:000009450', 'PR_EXT:000009450', 'PR_EXT:000009481', 'PR_EXT:keratin_6', 'PR_EXT:000009454', 'PR_EXT:000009167', 'PR_EXT:000009882', 'PR_EXT:000009495', 'PR_EXT:000009495', 'PR_EXT:000010425']
17002498	302	['Biotinylated secondary antibodies (donkey anti-rabbit and goat anti-mouse IgG, 1:250; Jackson ImmunoResearch, West Grove, Pennsylvania, United States), followed by the Vectastain Elite ABC kit (Vector Laboratories) were used for detection.']	(52525, 52764)	['GO:0042571', 'GO:0071735', 'MOP:0000093', 'NCBITaxon:9793', 'NCBITaxon:9986', 'NCBITaxon:9925', 'NCBITaxon:10088']
17002498	303	["The slides were stained with DAB and counterstained with Mayer's hematoxylin."]	(52765, 52842)	['CHEBI:51686']
17002498	304	['In situ hybridization.']	(52844, 52866)	['GO:0097617']
17002498	305	['Section ISH using rat Shh probe [37] and whole-mount ISH using β-catenin probe [38] were performed as previously described [39,40].']	(52868, 52999)	['CHEBI_SO_EXT:molecular_probe', 'CHEBI_SO_EXT:molecular_probe', 'NCBITaxon:10114', 'PR_EXT:000014841', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'CHEBI_SO_EXT:molecular_probe', 'CHEBI_SO_EXT:molecular_probe']
17002498	306	['Riboprobes labeled with DIG were detected with BM purple AP substrate precipitation solution (Roche).']	(53000, 53101)	['CHEBI_SO_EXT:riboprobe', 'CHEBI_SO_EXT:molecular_label_or_mark_or_tag_process', 'CHEBI:42098', 'CHEBI:75958', 'GO_PR_EXT:alkaline_phosphatase', 'GO_PR_EXT:alkaline_phosphatase', 'CHEBI_SO_EXT:riboprobe', 'CHEBI_SO_EXT:molecular_label_or_mark_or_tag_process']
17002498	307	['Supporting Information\n\nFigure S1\n\nMultiple Intestinal Neoplasia in ApcΔ580 Mice\n\n(A) A representative appearance of small intestine of 4-month-old mouse.']	(53103, 53257)	['NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122', 'UBERON:0000160', 'UBERON:0002108', 'UBERON:0002108']
17002498	308	['Scale bar, 1.5 mm.']	(53258, 53276)	[]
17002498	309	['(B) Histological analysis of longitudinal section of small intestine shown in (A) by H&E staining.']	(53278, 53376)	['CHEBI:51686', 'CHEBI_EXT:eosin', 'UBERON:0002108', 'UBERON:0002108']
17002498	310	['Scale bar, 100 μm.']	(53377, 53395)	[]
17002498	311	['(C) The typical histopathological appearance of an adenoma shown in (B).']	(53397, 53469)	[]
17002498	312	['Scale bar, 20μm.']	(53470, 53486)	[]
17002498	313	['(621 KB PPT)\n\nClick here for additional data file.']	(53488, 53538)	[]
17002498	314	['Figure S2\n\nSkin Permeability Assay and Neonatal Mice\n\n(A) Skin permeability assay of E18.5 embryos.']	(53540, 53639)	['NCBITaxon:10088', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'PATO_UBERON_EXT:neonate_or_newborn', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0000922']
17002498	315	['Both normal (N) and KA mutant (M) embryos can exclude the blue dye at this age, showing no defects in skin barrier function.']	(53640, 53764)	['CHEBI_EXT:37958', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0000922', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	316	['Note slight pigmentations in pinnnae and “birthmark” in the forehead of mutant embryo (B), which are present at P1 (C), and become prominent as they grow.']	(53765, 53919)	['GO_PATO_EXT:biological_pigmentation_process_or_quality', 'GO:0040007', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0001757', 'UBERON:0008200', 'UBERON:0000922']
17002498	317	['(749 KB PPT)\n\nClick here for additional data file.']	(53921, 53971)	[]
17002498	318	['Figure S3\n\nImmunochemical Examination of P13 Normal and Mutant Thymi\n\n(A–E) P13 normal thymus.']	(53973, 54067)	['SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370', 'UBERON:0002370']
17002498	319	['(F–K) P13 mutant thymus.']	(54068, 54092)	['SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370']
17002498	320	['Stained with K8 (A), (D), (F), (I), K1 (B), (E), (G), (J), and involucrin (C), (H), (K).']	(54093, 54181)	['PR_EXT:000009495', 'PR_EXT:000009450', 'PR_EXT:000009167']
17002498	321	['Scale bars, 100 μm for (A–C), (F–H), (J–K) and 20 μm for (D–E), (I).']	(54182, 54250)	[]
17002498	322	['Note the lack of involucrin staining in normal thymus but varying degree of positive cells in mutant thymus.']	(54251, 54359)	['CL_GO_EXT:cell', 'CL_GO_EXT:cell', 'PR_EXT:000009167', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370', 'UBERON:0002370']
17002498	323	['(6.4 MB PPT)\n\nClick here for additional data file.']	(54361, 54411)	[]
17002498	324	['Accession Numbers\n\nThe GenBank ((http://www.ncbi.nlm.nih.gov/Genbank) accession numbers for the genes and gene products discussed in this paper are Apc (NM_007462), β-catenin (NM_007614), AXIN 2 (NM_004655), plakoglobin (NM_002230), Asef (NM_015320), kinesin superfamily–associated protein 3 (NM_014970), EB1 (NM_012325), human homolog of Drosophila Discs large (U13897), Lef1 (NM_010703), Dkk1 (NM_010051), K1 (NM_008473), K5 (NM_027011), K6 (NM_008476), K8 (NM_031170), K14 (NM_016958), involucrin (NM_008412), loricrin (NM_008508), and Shh (NM_009170).']	(54413, 54968)	['CHEBI_PR_EXT:protein', 'NCBITaxon:9606', 'NCBITaxon:7215', 'PR_EXT:000004122', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000004527', 'PR_EXT:000004527', 'PR_EXT:000009235', 'PR_EXT:000004257', 'PR_EXT:000009322', 'PR_EXT:000009322', 'PR_EXT:000009322', 'PR_EXT:000009322', 'PR_EXT:000009322', 'PR_EXT:000009322', 'PR_EXT:000010170', 'PR_EXT:000006511', 'PR_EXT:000006511', 'PR_EXT:000006511', 'PR_EXT:000006511', 'PR_EXT:000006511', 'PR_EXT:000009751', 'PR_EXT:000006499', 'PR_EXT:000009450', 'PR_EXT:000009481', 'PR_EXT:keratin_6', 'PR_EXT:000009495', 'PR_EXT:000009454', 'PR_EXT:000009167', 'PR_EXT:000009882', 'PR_EXT:000014841', 'SO_EXT:0000704', 'SO_EXT:gene_product', 'SO_EXT:gene_product', 'SO_EXT:0000853']
17002498	325	['Abbreviations\n\nAPC - adenomatous polyposis coli\n\nCKO - conditional knockout\n\nE - embryonic day\n\nES - embryonic stem\n\nFAP - familial adenomatous polyposis\n\nFRT - FLP recognition target\n\nISH - in situ hybridization\n\nK14 - keratin 14\n\nORS - outer root sheath\n\nP - postnatal day\n\nTEC - thymic epithelial cell\n\nFigures and Tables\n\nFigure 1\n\nGeneration of the Conditional Apc Allele\n\n(A) Schematic diagram of exons 14 and 15 of the mouse Apc gene, the targeting vector, and the resulting conditional allele with 2 LoxP sites sandwiching the exon 14.']	(54970, 55513)	['CL:0002293', 'CL:0002293', 'CL:0002293', 'CL:0002293', 'GO:0007567', 'CL_GO_EXT:cell', 'GO:0097617', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:P03870', 'PR_EXT:000009454', 'PR_EXT:000009454', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:0000350', 'SO_EXT:0000350', 'SO_EXT:0000350', 'SO_EXT:0000350', 'SO_EXT:0001023', 'SO_EXT:0000147', 'SO_EXT:0000704', 'SO_EXT:0001644', 'SO_EXT:0001644', 'SO_EXT:0001023', 'SO_EXT:0000346', 'SO_EXT:0000346', 'SO_EXT:0000147', 'UBERON:0000922', 'UBERON:0000922', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0005942', 'UBERON:0003846', 'UBERON:0003846']
17002498	326	['The PGK-neomycin cassette was inserted within intron 14 by recombineering technique.']	(55514, 55598)	['CHEBI:7507', 'GO_EXT:phosphoglycerate_kinase', 'SO_EXT:0005853', 'SO_EXT:sequence_insertion_process', 'SO_EXT:0000188']
17002498	327	['This cassette is sandwiched by 2 FRT sites that could be removed by crossing to FLPe-expressing mice.']	(55599, 55700)	['GO:0010467', 'NCBITaxon:10088', 'SO_EXT:0005853', 'SO:0000357', 'SO_EXT:0000350', 'SO_EXT:0000350']
17002498	328	['Positions of PCR primers used for genotyping PCR (F2, R2, R4) and RT-PCR (F546 and R721) are indicated.']	(55701, 55804)	['GO_EXT:reverse_transcription_or_reverse_transcriptase', 'GO_EXT:reverse_transcription_or_reverse_transcriptase', 'SO_EXT:0000112']
17002498	329	['Positions of probe used for Southern blot analysis with NdeI sites are also shown.']	(55805, 55887)	['CHEBI_SO_EXT:molecular_probe', 'CHEBI_SO_EXT:molecular_probe']
17002498	330	['Upon Cre-mediated recombination, exon 14 is removed and leads to truncated Apc protein, of which the first 580 aa correspond to the normal.']	(55888, 56027)	['CHEBI_PR_EXT:protein', 'CHEBI_SO_EXT:amino_acid', 'GO_SO_EXT:sequence_rearrangement_process', 'PR_EXT:000004122', 'CHEBI_PR_EXT:protein', 'GO_SO_EXT:sequence_rearrangement_process', 'SO_EXT:0000147', 'SO_EXT:sequence_truncation_process', 'CHEBI_SO_EXT:amino_acid']
17002498	331	['(B) Southern blot analysis of NdeI-digested genomic tail DNA isolated from F1 mice of various Apc mouse lines (ApcCKON, ApcΔ580), hybridized to a 600-bp probe.']	(56029, 56188)	['CHEBI_SO_EXT:DNA', 'CHEBI_SO_EXT:molecular_probe', 'GO:0097617', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:genomic_DNA', 'SO_EXT:genomic_DNA', 'SO_EXT:0000028', 'CHEBI_SO_EXT:molecular_probe', 'UBERON:0002415']
17002498	332	['Tail genomic DNA from ApcCKON F1 mice derived from a modified ES clone showed a 12-kb band for the ApcCKON allele and a 10-kb band for the wild-type allele, whereas genomic DNA from the ApcΔ580 mouse was heterozygous for the ApcΔ580 allele (9.2-kb band).']	(56189, 56443)	['CHEBI_SO_EXT:DNA', 'CHEBI_SO_EXT:base', 'CHEBI_SO_EXT:base', 'CHEBI_SO_EXT:DNA', 'CHEBI_SO_EXT:base', 'CL:0002322', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:genomic_DNA', 'SO_EXT:genomic_DNA', 'SO_EXT:sequence_alteration_process', 'SO_EXT:sequence_cloned_entity', 'CHEBI_SO_EXT:base', 'SO_EXT:0001023', 'CHEBI_SO_EXT:base', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:0001023', 'SO_EXT:genomic_DNA', 'SO_EXT:genomic_DNA', 'SO_EXT:0001023', 'CHEBI_SO_EXT:base', 'UBERON:0002415']
17002498	333	['(C) Kaplan-Meier survival plot of ApcCKO/+ mice (thin solid line, n = 39), ApcCKO/CKO mice (thin dotted line, n = 57), ApcΔ580/+ mice (solid line, n = 51), and wild-type littermates (broken line, n = 21).']	(56445, 56649)	['NCBITaxon:10088', 'NCBITaxon:10088', 'NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:normal_or_wild_type_or_present', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality']
17002498	334	['Heterozygosity of the ApcΔ580 allele led to a significantly shortened survival (p < 0.0001), whereas those of heterozygous and homozygous ApcCKO mice had no significant difference to that of wild-type littermates.']	(56650, 56863)	['NCBITaxon:10088', 'PR_EXT:000004122', 'PR_EXT:000004122', 'SO_EXT:0001023', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality']
17002498	335	['Figure 2\n\nPostnatal Mortality and Stunted Growth in K14-cre; ApcCKO/CKO Mutant Mice\n\nAnimals whose genotype is either heterozygous or homozygous for the wild-type Apc allele are referred to as normal (N); those whose genotype are K14-cre; ApcCKO/CKO and show the presence of K14-cre–recombined mutant Apc allele are called mutant (M).']	(56865, 57199)	['GO:0007567', 'GO_EXT:biological_growth_entity_or_process', 'GO_SO_EXT:sequence_rearrangement_process', 'NCBITaxon:10088', 'NCBITaxon:33208', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000004122', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000009454', 'PR_EXT:000004122', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:genotype_or_entity_with_genotype', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:0001023', 'SO_EXT:genotype_or_entity_with_genotype', 'GO_SO_EXT:sequence_rearrangement_process', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:0001023', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:sequence_altered_entity_or_alteration_process']
17002498	336	['(A) Two P3 mutant mice, M1 and M2, and their normal littermates, showing size variation among mutants.']	(57201, 57303)	['NCBITaxon:10088', 'SO_EXT:sequence_altered_entity']
17002498	337	['(B) P8 mutant mouse (right) and a normal littermate.']	(57305, 57357)	['NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process']
17002498	338	['Note sparseness of hair coat and abnormal ears.']	(57358, 57405)	['UBERON:0010166', 'UBERON:0010166', 'UBERON:0001690']
17002498	339	['(C–D) Vibrissae of whisker pads are short and oddly angled in a P12 mutant mouse (C), relative to control (D).']	(57407, 57517)	['NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0006378']
17002498	340	['Note the lack of incisors in the mutant.']	(57518, 57558)	['SO_EXT:sequence_altered_entity', 'UBERON:0001098']
17002498	341	['(E) A P17 mutant mouse (right) with its littermate.']	(57560, 57611)	['NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process']
17002498	342	['Its bare forehead, dorsal median line, and abnormal ears are evident.']	(57612, 57681)	['UBERON:0008200', 'UBERON:0001690']
17002498	343	['(F) Growth curve of mutants and normal littermates.']	(57683, 57734)	['GO_EXT:biological_growth_entity_or_process', 'SO_EXT:sequence_altered_entity']
17002498	344	['Mutants exhibit stunted growth, which became more prominent as they aged, and weigh significantly less than littermates from P8 (p < 0.05).']	(57735, 57874)	['GO_EXT:biological_growth_entity_or_process', 'GO_PATO_EXT:aging_or_agedness', 'SO_EXT:sequence_altered_entity']
17002498	345	['(G) Comparison of mutant and normal thymus from P3 mice.']	(57876, 57932)	['NCBITaxon:10088', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370']
17002498	346	['The mutant thymus (left) is dramatically smaller for its age compared to the normal littermate (right).']	(57933, 58036)	['SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370']
17002498	347	['The scale bar equals 1 mm.']	(58037, 58063)	[]
17002498	348	['(H) Skeletal preparations of normal (left) and mutant (right), showing differences in development of both incisor (I) and molar (M) teeth.']	(58065, 58203)	['SO_EXT:sequence_altered_entity', 'UBERON:0004288', 'UBERON:0001098', 'UBERON:0001098', 'UBERON:0003655', 'UBERON:0003655', 'UBERON:0001098', 'UBERON:0001098', 'UBERON:0003655', 'UBERON:0003655']
17002498	349	['Figure 3\n\nTissue-Specific Detection and Expression of Deleted Apc Alleles\n\n(A) Tissue-specific genotyping PCR.']	(58205, 58315)	['GO:0010467', 'PR_EXT:000004122', 'SO_EXT:sequence_deletion_process', 'SO_EXT:0001023', 'UBERON:0000479', 'UBERON:0000479']
17002498	350	['Only genomic DNA samples from the skin (S) and thymus (T), but not liver (L) of mice positive for K14-cre show the presence of deleted ApcΔ580 allele.']	(58316, 58466)	['CHEBI_SO_EXT:DNA', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000004122', 'SO_EXT:genomic_DNA', 'SO_EXT:genomic_DNA', 'SO_EXT:sequence_deletion_process', 'SO_EXT:0001023', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0002370', 'UBERON:0002370', 'UBERON:0002107', 'UBERON:0002107']
17002498	351	['(B) Genotype- and tissue-specific expression of the truncated Apc transcripts.']	(58468, 58546)	['GO:0010467', 'PR_EXT:000004122', 'SO_EXT:genotype_or_entity_with_genotype', 'SO_EXT:sequence_truncation_process', 'SO_EXT:0000673', 'UBERON:0000479']
17002498	352	['A representative gel of RT-PCR using primers F546 and R721, showing that only RNA from the skin and thymus but not liver of mice positive for K14-cre have transcripts from both wild-type (528 bp) and deleted (313 bp) Apc alleles.']	(58547, 58776)	['CHEBI_SO_EXT:RNA', 'GO_EXT:reverse_transcription_or_reverse_transcriptase', 'GO_EXT:reverse_transcription_or_reverse_transcriptase', 'NCBITaxon:10088', 'PR_EXT:000009454', 'PR_EXT:000004122', 'SO_EXT:0000112', 'CHEBI_SO_EXT:RNA', 'SO_EXT:0000673', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:wild_type_entity_or_quality', 'SO_EXT:0000028', 'SO_EXT:sequence_deletion_process', 'SO_EXT:0000028', 'SO_EXT:0001023', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0002370', 'UBERON:0002107']
17002498	353	['Figure 4\n\nHistological and Immunochemical Examination of P12 Skin and Teeth\n\n(A–E) P12 normal skin.']	(58778, 58877)	['UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0001091', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	354	['(F–J) P12 mutant skin.']	(58878, 58900)	['SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	355	['(K–N) P12 normal oral cavity.']	(58901, 58930)	['UBERON:0000167', 'UBERON:0000167']
17002498	356	['(O–R) P12 mutant oral cavity.']	(58931, 58960)	['SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0000167', 'UBERON:0000167']
17002498	357	['Stained with H&E for histology (A, F, K–L, O–P), Ki67 (B, G), β-catenin (C, H, M, Q), K14 (D, I, N, R), and K6 (E, J).']	(58961, 59079)	['CHEBI:51686', 'CHEBI_EXT:eosin', 'PR_EXT:000010425', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009454', 'PR_EXT:keratin_6']
17002498	358	['Aberrant follicular morphogenesis, characterized by formation of irregularly spaced, nonpolarized hair follicles, in mutant skin is evident.']	(59080, 59220)	['GO:0009653', 'GO:0001942', 'GO:0001942', 'GO:0001942', 'GO:0001942', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON_EXT:follicle', 'UBERON:0002073', 'UBERON:0002073', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	359	['Despite the abnormal histology, proliferation seems to be confined to hair bulb-like structures (arrows in [G], inset [G′] at higher magnification), but in mutant skin (arrows in [H], inset [H′] at higher magnification) and oral cavity (arrows in insets [Q′] at higher magnification) elevated cytosolic localization of β-catenin is detected in some cells.']	(59221, 59576)	['CL_GO_EXT:cell', 'GO:0008283', 'GO_PATO_EXT:biological_localization_process_or_quality', 'GO:0005829', 'CL_GO_EXT:cell', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0005932', 'UBERON:0005932', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON:0000167', 'UBERON:0000167']
17002498	360	['Scale bars: 50 μm for (A–F), (H–J); 250 μm for (K) and (O); 100 μm for (G), (L–N), (P–R); 20 μm for (Q′).']	(59577, 59682)	[]
17002498	361	['Figure 5\n\nExpression of Shh and β-catenin Transcripts in Normal (ApcCKO/CKO) and Mutant (K14-cre; ApcCKO/CKO) Embryonic Skin\n\n(A–D) Section ISH with Shh probe in E14.5 normal (A), E14.5 mutant (B), E16.5 normal (C), and E16.5 mutant (D) skin.']	(59684, 59926)	['CHEBI_SO_EXT:molecular_probe', 'GO:0010467', 'PR_EXT:000014841', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000004122', 'PR_EXT:000009454', 'PR_EXT:000004122', 'PR_EXT:000014841', 'SO_EXT:0000673', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'CHEBI_SO_EXT:molecular_probe', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0000922', 'UBERON_EXT:zone_of_skin_or_skin_of_body', 'UBERON_EXT:zone_of_skin_or_skin_of_body']
17002498	362	['Broken lines indicate the interface between epithelium and mesenchyme.']	(59927, 59997)	['UBERON:0000483', 'UBERON:0003104']
17002498	363	['Scale bars: 50 μm.']	(59998, 60016)	[]
17002498	364	['Whole mount in situ detection of β-catenin in E15.5 normal (E, G), mutant (F, H) embryos.']	(60017, 60106)	['PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0000922']
17002498	365	['Aberrant initiation of multiple hair placodes is evident at E14.5.']	(60107, 60173)	['UBERON:0005086', 'UBERON:0005086']
17002498	366	['Loss of K14-driven Apc loss caused aberrant pattern formation (F′) and formed ectopic hair placodes in normally hairless foot pads (H, arrows) which are absent in normal (G).']	(60174, 60348)	['PR_EXT:000009454', 'PR_EXT:000004122', 'UBERON:0005086', 'UBERON:0005086', 'UBERON:0001037', 'UBERON:0013623', 'UBERON:0013623']
17002498	367	['Figure 6\n\nHistological and Immunochemical Examination of Thymus\n\n(A–D) P3 normal thymus.']	(60350, 60438)	['UBERON:0002370', 'UBERON:0002370']
17002498	368	['(E–G) Mild P3 mutant thymus.']	(60439, 60467)	['SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370']
17002498	369	['(H–K) Severe P3 mutant thymus.']	(60468, 60498)	['SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370']
17002498	370	['(L–O) P13 mutant thymus.']	(60499, 60523)	['SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370']
17002498	371	['Stained with H&E for histology (A, E, H, L), BrdU (B, I, M), β-catenin (C, F, J, N), and K14 (D, G, K, O).']	(60524, 60630)	['CHEBI:51686', 'CHEBI_EXT:eosin', 'CHEBI:472552', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000002198', 'PR_EXT:000009454']
17002498	372	['(B) Actively dividing thymocytes are visible at the superficial edge of cortex of normal P3 thymus.']	(60631, 60730)	['CL:0000893', 'UBERON:0002123', 'UBERON:0002123', 'UBERON:0002123']
17002498	373	['Note the progression of histological abnormalities in the mutant thymus from mild P3, severe P3 to P13 (A, E, H, L).']	(60731, 60847)	['SO_EXT:sequence_altered_entity_or_alteration_process', 'UBERON:0002370']
17002498	374	['Scale bars, 20 μm.']	(60848, 60866)	[]
17002498	375	['Table 1\n\nGenotype Distribution of Progeny from the Matings\n\nFootnotes\n\nCompeting interests.']	(60868, 60959)	['GO:0007618', 'SO_EXT:genotype_or_entity_with_genotype']
17002498	376	['The authors have declared that no competing interests exist.']	(60960, 61020)	[]
17002498	377	['A previous version of this article appeared as an Early Online Release on July 28, 2006 (DOI: 10.1371/journal.pgen.0020146.eor).']	(61022, 61150)	[]
17002498	378	['Author contributions.']	(61152, 61173)	[]
17002498	379	['M. Kuraguchi and R. Kucherlapati conceived and designed the experiments.']	(61174, 61246)	[]
17002498	380	['M. Kuraguchi, X. Wang, R. Bronson, R. Rothenberg, N. Ohene-Baah, J. Lund, and M. Kucherlapati performed the experiments.']	(61247, 61367)	[]
17002498	381	['M. Kuraguchi analyzed the data.']	(61368, 61399)	[]
17002498	382	['R. Maas contributed reagents/materials/analysis tools.']	(61400, 61454)	['CHEBI_EXT:33893']
17002498	383	['M. Kuraguchi wrote the paper.']	(61455, 61484)	[]
17002498	384	['Funding.']	(61486, 61494)	[]
17002498	385	['This work was supported by grants from the National Cancer Institute (CA-084301), the National Institute of Environmental Health Sciences (ES-11040), and the National Institute of Dental and Craniofacial Research (DE-11697, DE-16140).']	(61495, 61729)	['UBERON:0001091', 'UBERON_EXT:face_or_skull']
